This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
ILD, hospital admission 2, with pulmonary infections
ILD_HOSPITAL_PULM_INFECT
interstitial lung disease: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
167823 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
3759 |
6. Filter based on genotype QC (FinnGen only) |
3759 |
Control definitions (FinnGen only)
- Control conditions
- not PULM_INFECTIONS
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
ILD, hospital admission 2, with pulmonary infections
based on the number of shared cases.
Similar with more cases:
- ILD, hospital admissions
- Interstitial lung disease
- Other interstitial pulmonary diseases
- Interstitial lung disease endpoints
- Respiratory diseases principally affecting the interstitium, IBD co-morbidites
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3759 | 1497 | 2262 |
| Unadjusted period prevalence (%) | 0.80 | 0.51 | 1.00 |
| Median age at first event (years) | 68.81 | 66.46 | 70.37 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3310
- Matched controls
- 33092
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
176.7
323.0
1570
168
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
28.9
323.0
652
278
TGC00
NOMESCO Finland
Bronchial lavation
56.0
323.0
790
184
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
12.4
323.0
1232
1509
R06.0
ICD-10 Finland
Dyspnoea
4.8
323.0
1452
4633
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
142.5
323.0
888
85
H02AB06
ATC
prednisolone; systemic
10.9
323.0
2692
9469
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
203.9
323.0
1736
178
UGC12
NOMESCO Finland
Flexible bronchoscopy
20.2
323.0
1285
1006
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.5
323.0
2292
9585
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
250.1
323.0
1046
61
J01MA14
ATC
moxifloxacin; systemic
12.8
323.0
744
732
J18.9
ICD-10 Finland
Pneumonia, unspecified
126.8
323.0
2463
741
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
7.2
323.0
987
1852
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
35.4
323.0
1160
497
R03AC02
ATC
salbutamol; inhalant
4.0
306.9
2075
9739
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
8.8
277.0
646
892
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.8
271.1
1655
6844
XG410
NOMESCO Finland
Flow-volume spirometry
12.1
261.4
502
481
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
6.1
258.5
795
1624
R03BB04
ATC
tiotropium bromide; inhalant
6.7
257.3
734
1358
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
9.7
256.7
557
674
J96.1
ICD-10 Finland
Chronic respiratory failure
27.1
251.6
353
145
GD1AD
NOMESCO Finland
Thorax CT examination
11.3
235.6
467
473
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
8.8
225.6
517
679
284
Kela drug reimbursment
Nintedanib and pirfenidone
73.1
225.0
257
38
C03CA01
ATC
furosemide; systemic
3.4
222.0
1593
7135
L04AX01
ATC
azathioprine; systemic
11.8
220.8
428
412
J01MA12
ATC
levofloxacin; systemic
4.2
220.7
1011
3116
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
15.3
217.5
373
273
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.3
202.5
900
2665
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
7.8
198.2
493
730
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
14.6
195.2
341
259
A02BC02
ATC
pantoprazole; systemic
3.1
192.3
2433
15527
356
Kela drug reimbursment
Nintedanib and pirfenidone
74.5
184.3
210
30
R50.9
ICD-10 Finland
Fever, unspecified
4.8
183.5
701
1767
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.9
175.8
1719
9033
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
4.7
168.1
639
1589
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
3.1
165.1
1204
5159
J45.9
ICD-10 Finland
Asthma, unspecified
3.9
161.8
777
2406
R03AK06
ATC
salmeterol and fluticasone; inhalant
4.3
160.7
687
1912
L04AA06
ATC
mycophenolic acid; systemic
23.9
159.9
232
104
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
46.9
158.7
195
44
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
5.0
156.1
554
1273
L04AX05
ATC
pirfenidone; oral
77.2
155.3
176
24
I50.9
ICD-10 Finland
Heart failure, unspecified
3.6
154.0
816
2730
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
10.9
151.4
303
304
J01FA06
ATC
roxithromycin; oral
2.7
144.6
1491
7782
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
13.5
141.1
253
201
J01AA02
ATC
doxycycline; systemic
2.9
140.3
2663
19492
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.4
139.8
567
1483
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
9.7
137.8
293
328
M05BA04
ATC
alendronic acid; oral
4.5
136.4
542
1387
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
58.2
136.2
161
29
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
77.5
130.6
148
20
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
3.2
126.7
807
3046
P01BA02
ATC
hydroxychloroquine; oral
4.9
126.4
452
1033
J47
ICD-10 Finland
Bronchiectasis
19.5
126.0
195
106
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
6.0
124.2
369
679
TPH04
NOMESCO Finland
Cathetrisation of vein
2.9
122.2
910
3807
R05
ICD-10 Finland
Cough
3.0
118.1
819
3259
J84.0
ICD-10 Finland
Alveolar and parietoalveolar conditions
310.6
117.9
119
*
R81
ICPC
Pneumonia
11.4
117.6
228
213
R02
ICPC
Shortness of breath/dyspnoea
3.7
116.8
586
1832
H02AB07
ATC
prednisone; oral
3.4
115.6
652
2233
J01CA04
ATC
amoxicillin; systemic
2.5
115.2
2524
18621
46599
ICD-8 Finland
Acute upper respiratory infection of multiple or unspecified sites
+∞
112.1
107
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.3
110.7
367
766
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
5.4
108.9
354
722
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.0
108.5
745
2922
L01XE31
ATC
[U] nintedanib; oral
84.3
101.8
114
14
Z94.2
ICD-10 Finland
Lung transplant status
260.4
99.2
101
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.7
98.7
830
3667
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.9
98.3
698
2778
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
+∞
97.3
93
*
J45.1
ICD-10 Finland
Nonallergic asthma
4.8
96.6
346
782
I50.0
ICD-10 Finland
Congestive heart failure
3.9
95.7
439
1257
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
95.5
1142
6079
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
19.8
95.2
146
77
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
+∞
94.2
90
*
GDG10
NOMESCO Finland
Bilateral transplantation of lung
325.3
93.3
94
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.9
93.0
418
1175
R4110
NOMESCO Finland
Physiotherapy
2.4
92.8
1025
5227
XG466
NOMESCO Finland
Sleep oxymetry
7.7
92.6
224
307
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.4
89.9
943
4671
R03AK07
ATC
formoterol and budesonide; inhalant
2.8
87.2
641
2587
WX892
NOMESCO Finland
Monitored bed care
3.9
85.7
388
1094
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.0
85.4
557
2077
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.6
84.1
316
747
N02AX02
ATC
tramadol; systemic, rectal
2.1
83.7
1509
9512
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
4.3
82.9
328
816
L04AD01
ATC
ciclosporin; systemic
14.2
82.2
143
105
A07EC01
ATC
sulfasalazine; oral, rectal
3.9
81.8
373
1056
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.9
80.4
566
2209
Z3226
NOMESCO Finland
Physiotherapist
2.5
80.0
725
3289
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
8.5
78.9
179
221
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
16.8
78.9
128
79
TDM10
NOMESCO Finland
Puncture of maxillary antrum
10.1
77.4
159
165
127
Kela drug reimbursment
Transplant complication
15.6
76.7
128
85
J45.0
ICD-10 Finland
Predominantly allergic asthma
4.3
76.2
301
746
ZX120
NOMESCO Finland
Intravenous
3.4
75.8
414
1353
R03BA05
ATC
fluticasone; inhalant
2.7
75.6
599
2508
XF400
NOMESCO Finland
ECG with 12 standard connections
2.5
75.5
699
3195
A02BC01
ATC
omeprazole; systemic
2.1
74.4
1055
5923
R04.2
ICD-10 Finland
Haemoptysis
5.7
72.8
221
411
A03
ICPC
Fever
3.1
72.2
449
1608
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
72.2
785
3889
J01FA10
ATC
azithromycin; systemic
1.9
71.1
1569
10471
J01DB01
ATC
cefalexin; oral
2.1
70.8
2519
20097
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
3.9
70.4
316
878
48499
ICD-8 Finland
Acute interstitial pneumonia
98.5
70.2
77
8
R03DC03
ATC
montelukast; oral
2.9
69.4
487
1883
J43.9
ICD-10 Finland
Emphysema, unspecified
9.4
69.2
147
162
R03BA02
ATC
budesonide; inhalant
2.6
69.0
589
2561
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
349.2
68.8
69
*
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
5.0
68.8
234
496
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
95.9
68.1
75
8
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
234.7
67.5
69
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.7
67.1
528
2188
R03AK08
ATC
formoterol and beclometasone; inhalant
6.1
66.4
189
324
C07AB07
ATC
bisoprolol; oral
1.9
66.4
1769
12519
A07AA02
ATC
nystatin; oral
3.7
66.3
312
902
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
5.3
66.1
211
416
ZX108
NOMESCO Finland
Inhalation
41.9
65.7
82
20
J01FF01
ATC
clindamycin; systemic
2.1
65.6
898
4909
ZXE00
NOMESCO Finland
One hour or less
1.9
65.4
1323
8458
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
26.7
65.4
91
35
WW200
NOMESCO Finland
Immunization
7.0
65.2
167
248
R05
ICPC
Cough
2.3
64.9
727
3627
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
59.8
64.8
76
13
R03BA08
ATC
ciclesonide; inhalant
3.5
64.6
324
985
L04AA13
ATC
leflunomide; oral
7.7
64.2
155
211
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
6.0
63.5
184
323
Z3231
NOMESCO Finland
Registered nurse
2.0
62.3
973
5602
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.9
61.5
1423
9485
N02AA05
ATC
oxycodone; systemic
2.4
61.1
600
2795
J12.8
ICD-10 Finland
Other viral pneumonia
608.8
60.9
60
*
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
110.4
60.0
65
6
Z2221
NOMESCO Finland
Medical doctor
2.0
60.0
932
5337
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.0
59.7
938
5398
J15.8
ICD-10 Finland
Other bacterial pneumonia
207.0
59.2
61
*
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
6.3
59.1
163
268
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
5.7
58.6
176
323
N02BE01
ATC
paracetamol; systemic, rectal
2.0
57.7
2724
22984
JN4BD
NOMESCO Finland
Extensive body CT
2.6
57.4
470
1979
L01EX09
ATC
nintedanib; oral
73.8
57.2
65
9
TPH07
NOMESCO Finland
Cathetrisation of artery
2.7
57.2
441
1792
A02BC05
ATC
esomeprazole; systemic
1.9
57.1
1312
8650
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
13.0
56.7
102
81
B01AA03
ATC
warfarin; systemic
2.0
56.1
897
5171
R28
ICPC
Limited function/disability (R)
10.8
56.0
110
105
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.7
56.0
266
772
5150X
ICD-9 Finland
Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]
46.2
55.6
68
15
J46
ICD-10 Finland
Status asthmaticus
8.8
55.0
121
142
Z2446
NOMESCO Finland
Social worker
3.7
54.5
254
725
R03BA01
ATC
beclometasone; inhalant
2.5
54.5
491
2174
H02AB04
ATC
methylprednisolone; systemic
2.5
54.4
496
2211
J96.0
ICD-10 Finland
Acute respiratory failure
12.6
53.8
98
80
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
+∞
52.2
50
*
R03DA04
ATC
theophylline; systemic, rectal
3.6
51.9
246
712
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.8
51.6
369
1430
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
6.4
51.2
139
224
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
55.5
50.7
60
11
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.9
50.6
993
6138
WX725
NOMESCO Finland
Noninvasive ventilation
4.1
49.8
204
519
J01FA09
ATC
clarithromycin; systemic
1.9
49.7
875
5192
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
3.0
49.6
314
1124
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
6.8
49.4
129
197
N03AX16
ATC
pregabalin; oral
2.0
48.7
749
4213
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.3
48.4
488
2280
ZXD05
NOMESCO Finland
Urgent procedure
1.8
47.2
985
6185
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
4.1
47.1
194
496
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
47.1
321
1204
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
3.6
47.1
228
671
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.0
46.9
286
998
M04AA01
ATC
allopurinol; systemic
2.2
46.9
559
2821
J01FA15
ATC
telithromycin; oral
2.9
46.5
315
1177
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
16.8
46.0
74
45
J45.8
ICD-10 Finland
Mixed asthma
5.8
45.5
134
240
J20
ICD-10 Finland
Acute bronchitis
2.8
45.4
312
1176
R06AE07
ATC
cetirizine; oral
1.8
45.1
1167
7830
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
6.7
44.6
117
180
N05CF01
ATC
zopiclone; oral
1.8
44.3
1090
7191
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
443.3
44.3
44
*
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
12.0
44.2
82
70
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
7.3
43.9
108
152
R99
ICPC
Respiratory disease other
7.0
43.8
111
163
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
43.7
1177
7975
J01MA02
ATC
ciprofloxacin; systemic
1.7
43.6
1289
8985
R03AC03
ATC
terbutaline; inhalant
2.4
43.3
421
1926
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
43.2
461
2204
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.8
42.9
944
5993
XX4BW
NOMESCO Finland
NA
39.2
42.9
54
14
48609
ICD-8 Finland
Pneumonia, unspecified
+∞
42.8
41
*
A28
ICPC
Limited function/disability NOS
2.0
42.4
610
3321
WX722
NOMESCO Finland
PEEP
3.6
42.3
202
587
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
42.1
857
5296
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
5.6
42.0
126
231
XF600
NOMESCO Finland
Bloodpressure measurement
3.0
42.0
263
933
J01DA01
ATC
[U] cefalexin; systemic
1.6
41.9
1872
14591
4610A
ICD-9 Finland
Acute sinusitis, Maxillary
+∞
41.7
40
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
6.8
41.6
108
164
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.7
41.5
1151
7836
A02BC03
ATC
lansoprazole; oral
1.8
41.5
969
6260
XW000
NOMESCO Finland
Bone marrow biopsy
3.6
41.3
195
561
Z51.5
ICD-10 Finland
Palliative care
2.9
40.9
272
1000
A41.9
ICD-10 Finland
Sepsis, unspecified
4.2
40.8
162
401
46309
ICD-8 Finland
Acute tonsillitis, Unspecified
+∞
40.7
39
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.3
40.7
430
2043
R03AC12
ATC
salmeterol; inhalant
3.6
40.5
190
544
R06.2
ICD-10 Finland
Wheezing
4.1
40.5
167
428
WX872
NOMESCO Finland
Intensive care
3.2
40.4
229
758
JN4AD
NOMESCO Finland
Body CT examination
2.7
40.1
305
1220
SPAT1263
SPAT
Sampling
1.7
39.7
1292
9179
A01AB09
ATC
miconazole; local oral
2.5
39.6
325
1357
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
4.0
39.5
167
437
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
5.3
39.4
124
241
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
7.3
39.3
97
137
WZC30
NOMESCO Finland
Teaching
2.2
38.5
455
2272
R03BB01
ATC
ipratropium bromide; inhalant
3.5
38.1
189
566
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
37.5
967
6398
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.7
37.3
171
481
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.7
37.0
262
1003
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
36.9
614
3514
G47.3
ICD-10 Finland
Sleep apnoea
1.9
36.8
637
3696
C01DA14
ATC
isosorbide mononitrate; oral
1.8
36.7
702
4216
L88
ICPC
Rheumatoid/seropositive arthritis
4.0
36.7
153
396
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.3
36.5
379
1780
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.6
36.5
288
1175
R5140
NOMESCO Finland
Monitoring the use of the aid
2.3
36.2
372
1737
L04AA01
ATC
[U] ciclosporin; systemic
8.0
36.0
83
106
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
9.7
35.9
74
78
J80
ICD-10 Finland
Adult respiratory distress syndrome
44.5
35.9
44
10
D07AC01
ATC
betamethasone; topical
1.7
35.8
1055
7238
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
35.7
1031
7030
GDA10
NOMESCO Finland
Biopsy of lung
28.6
35.5
48
17
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
13.4
35.4
62
47
WX721
NOMESCO Finland
Oxygen concentrator therapy
40.5
35.3
44
11
E0000UV
ATC
NA
1.6
35.2
1126
7889
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
34.9
1209
8649
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.1
34.9
199
661
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
7.0
34.9
88
129
WX726
NOMESCO Finland
High-flow oxygen therapy
181.8
34.8
36
*
R03AC13
ATC
formoterol; inhalant
3.4
34.6
179
554
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.3
34.4
183
578
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
57.8
34.2
40
7
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
12.4
34.2
62
51
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.2
34.1
384
1871
UJF32
NOMESCO Finland
Coloscopy
1.7
34.1
847
5510
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
34.0
448
2337
XG474
NOMESCO Finland
Exhalation nntrogen oxide
5.2
33.9
108
213
AN1
HP
Coronary angiography
2.0
33.6
505
2772
XG460
NOMESCO Finland
Short time oxymetry
6.1
33.6
93
155
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.6
33.5
262
1059
C03DA01
ATC
spironolactone; oral
2.1
33.5
399
1992
A46
ICD-10 Finland
Erysipelas
2.0
33.4
483
2613
GX1K5
NOMESCO Finland
Diffusion capacity
38.7
33.4
42
11
J12.9
ICD-10 Finland
Viral pneumonia, unspecified
+∞
33.4
32
*
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
5.1
33.4
108
217
SPAT1262
SPAT
Handing over of treatment supplies
1.8
33.1
638
3829
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
10.3
32.8
65
64
WX882
NOMESCO Finland
High dependency care
4.4
32.7
123
289
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
4.1
32.6
132
333
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.2
32.5
176
564
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
5.9
32.4
93
162
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
5.0
32.1
106
218
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.7
32.1
908
6119
J18
ICD-10 Finland
Pneumonia, organism unspecified
16.7
31.9
51
31
AA1AD
NOMESCO Finland
CT of head and brain
1.7
31.8
789
5114
SPAT1255
SPAT
Intravenous administration of medicine
2.6
31.8
239
947
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.7
31.4
870
5818
J12.1
ICD-10 Finland
Respiratory syncytial virus pneumonia
+∞
31.3
30
*
M05BA07
ATC
risedronic acid; oral
3.4
31.1
155
466
NH3EA
NOMESCO Finland
Feet X-ray examination with load
5.4
31.1
96
183
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
11.5
31.0
58
51
J45
ICD-10 Finland
Asthma
2.5
30.9
265
1128
J84
ICD-10 Finland
Other interstitial pulmonary diseases
315.6
30.9
31
*
B01AB05
ATC
enoxaparin; parenteral
1.6
30.9
957
6597
N06AX11
ATC
mirtazapine; oral
1.7
30.9
859
5747
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.1
30.8
365
1817
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.9
30.8
202
737
ZXE40
NOMESCO Finland
More than seven and less than nine hours
4.4
30.6
113
261
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.5
30.6
252
1051
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
5.0
30.4
100
205
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
6.0
30.2
85
145
D86.0
ICD-10 Finland
Sarcoidosis of lung
7.5
30.1
72
98
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
30.1
909
6214
F1246
NOMESCO Finland
NA
32.8
30.0
39
12
R01AD09
ATC
mometasone; nasal
1.6
29.9
1095
7865
J18.8
ICD-10 Finland
Other pneumonia, organism unspecified
68.5
29.9
34
5
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.8
29.8
204
763
R07.4
ICD-10 Finland
Chest pain, unspecified
1.7
29.6
836
5608
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.4
29.6
267
1166
ZXE20
NOMESCO Finland
More than three and less than five hours
1.9
29.5
478
2691
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
29.4
1240
9207
120
Kela drug reimbursment
Hypogammaglobulinaemia
+∞
29.2
28
*
Z3229
NOMESCO Finland
Other healthcare associate professional
2.2
28.9
304
1431
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.1
28.8
374
1933
J05AB11
ATC
valaciclovir; oral
2.0
28.8
390
2050
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
28.7
928
6442
R01AD08
ATC
fluticasone; nasal
1.7
28.7
706
4543
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
28.7
725
4701
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
3.5
28.7
139
409
R03AK11
ATC
formoterol and fluticasone; inhalant
4.9
28.7
96
201
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
16.9
28.4
45
27
C09AA05
ATC
ramipril; oral
1.6
28.4
904
6248
4660A
ICD-9 Finland
Acute bronchitis and bronchiolitis, Acute bronchitis
+∞
28.2
27
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
+∞
28.2
27
*
J20.5
ICD-10 Finland
Acute bronchitis due to respiratory syncytial virus
+∞
28.2
27
*
M13.9
ICD-10 Finland
Arthritis, unspecified
2.5
28.1
229
948
M10.9
ICD-10 Finland
Gout, unspecified
2.4
28.0
260
1151
J99.0*M05.1
ICD-10 Finland
Rheumatoid lung disease
146.2
27.7
29
*
J02AC01
ATC
fluconazole; systemic
1.6
27.6
903
6277
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.8
27.6
506
2967
M01CB01
ATC
sodium aurothiomalate; parenteral
5.8
27.6
79
138
I50.1
ICD-10 Finland
Left ventricular failure
2.7
27.4
194
740
ZXA10
NOMESCO Finland
Bilateral
1.7
27.3
613
3837
WX110
NOMESCO Finland
Local anesthesy
1.5
27.3
1858
15263
46699
ICD-8 Finland
Acute bronchitis and bronchiolitis
+∞
27.1
26
*
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
3.4
27.0
137
419
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
62.5
27.0
31
5
A06AD11
ATC
lactulose; oral
1.8
26.9
505
2982
E000001
ATC
NA
1.8
26.7
572
3522
F2680
NOMESCO Finland
NA
28.0
26.7
36
13
L01AA01
ATC
cyclophosphamide; systemic
14.2
26.6
45
32
XJC10
NOMESCO Finland
Oesophageal pH monitoring
14.8
26.5
44
30
R53
ICD-10 Finland
Malaise and fatigue
1.7
26.4
586
3650
J96.9
ICD-10 Finland
Respiratory failure, unspecified
12.5
26.3
47
38
X59
ICD-10 Finland
Exposure to unspecified factor
1.8
26.2
503
2992
4659X
ICD-9 Finland
Acute upper respiratory infections of multiple or unspecified sites, Unspecified site
+∞
26.1
25
*
WX002
NOMESCO Finland
Sedation and analgesia
1.7
25.9
628
4012
5AB14
NOMESCO Finland
NA
73.2
25.8
29
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.1
25.7
149
501
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
25.7
797
5444
2AX04
NOMESCO Finland
NA
136.0
25.6
27
*
M05BX04
ATC
denosumab; parenteral
2.7
25.5
184
711
XG405
NOMESCO Finland
Education on PEF monitoring
6.1
25.5
70
116
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
25.5
423
2393
R05FB02
ATC
cough suppressants and expectorants
1.5
25.5
1138
8483
N03AX12
ATC
gabapentin; oral
1.9
25.4
440
2525
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.6
25.4
779
5301
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
25.4
600
3805
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.3
25.3
95
224
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.6
25.3
193
770
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.8
25.3
168
618
SPAT1325
SPAT
Vaccination
1.5
25.3
1160
8698
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.8
25.2
109
293
ZXA00
NOMESCO Finland
Right side
1.6
25.1
871
6115
48509
ICD-8 Finland
Bronchopneumonia, unspecified
+∞
25.0
24
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
39.1
24.9
31
8
D64.9
ICD-10 Finland
Anaemia, unspecified
1.9
24.7
376
2062
R74
ICPC
Upper respiratory infection acute
1.7
24.7
555
3465
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
10.8
24.5
47
44
R96
ICPC
Asthma
2.3
24.4
245
1129
M54.5
ICD-10 Finland
Low back pain
1.6
24.3
830
5796
S97
ICPC
Chronic ulcer skin
2.5
24.3
200
833
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.9
24.3
151
533
L04AB04
ATC
adalimumab; parenteral
5.6
24.3
71
128
TK800
NOMESCO Finland
Hemodialysis
4.6
24.1
85
189
R95
ICPC
Chron obstructive pulmonary disease
3.7
24.0
107
295
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
56.4
24.0
28
5
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
3.5
23.9
116
343
J70.2
ICD-10 Finland
Acute drug-induced interstitial lung disorders
22.9
23.9
34
15
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
11.4
23.6
44
39
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.6
23.6
176
695
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.4
23.4
212
928
B99
ICD-10 Finland
Other and unspecified infectious diseases
4.6
23.4
82
181
R01AD12
ATC
fluticasone furoate; nasal
1.6
23.3
641
4227
J86.9
ICD-10 Finland
Pyothorax without fistula
11.4
23.1
43
38
I50
ICD-10 Finland
Heart failure
3.1
23.1
133
446
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.2
23.1
245
1157
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.5
23.0
191
798
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
22.9
888
6377
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
22.9
317
1674
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
8.4
22.8
50
60
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
22.8
286
1452
J43.8
ICD-10 Finland
Other emphysema
16.5
22.7
36
22
A02BA02
ATC
ranitidine; systemic
1.6
22.6
647
4307
M81.4
ICD-10 Finland
Drug-induced osteoporosis
14.2
22.6
38
27
H02AB09
ATC
hydrocortisone; systemic
4.6
22.6
80
179
B02.9
ICD-10 Finland
Zoster without complication
2.3
22.5
209
927
D07AC13
ATC
mometasone; topical
1.6
22.5
813
5739
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
4.4
22.5
82
189
L28
ICPC
Limited function/disability (L)
1.7
22.5
514
3215
5BA08
NOMESCO Finland
NA
11.8
22.4
41
35
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.2
22.4
233
1091
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
6.4
22.3
59
94
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
27.5
22.2
30
11
J43.2
ICD-10 Finland
Centrilobular emphysema
16.8
22.2
35
21
C01AA05
ATC
digoxin; systemic
1.9
22.1
329
1785
GAA31
NOMESCO Finland
Thoracoscopy
15.1
22.0
36
24
M79.6
ICD-10 Finland
Pain in limb
1.5
21.9
951
6993
ZXA05
NOMESCO Finland
Left side
1.5
21.9
811
5753
GX1D5
NOMESCO Finland
Flow volume spirometry
62.9
21.8
25
*
XX9XE
NOMESCO Finland
Other ultrasound examination
8.2
21.6
48
59
J67.9
ICD-10 Finland
Hypersensitivity pneumonitis due to unspecified organic dust
31.3
21.5
28
9
J05AB01
ATC
aciclovir; systemic
1.6
21.4
566
3686
J20.0
ICD-10 Finland
Acute bronchitis due to Mycoplasma pneumoniae
26.6
21.3
29
11
R4190
NOMESCO Finland
Nutritional therapy
3.6
21.3
99
284
J92.9
ICD-10 Finland
Pleural plaque without asbestos
5.0
21.2
69
141
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.4
21.2
181
769
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
3.7
21.1
95
265
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.1
21.1
243
1189
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
2.2
21.1
234
1128
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
4.6
21.1
73
160
A04
ICPC
Weakness/tiredness general
1.8
21.0
375
2169
I25.2
ICD-10 Finland
Old myocardial infarction
2.0
20.9
288
1518
P01AB01
ATC
metronidazole; oral, rectal
1.5
20.8
994
7443
SPAT1254
SPAT
Administration of medicine
1.7
20.7
447
2746
N02AA01
ATC
morphine; systemic, rectal
4.4
20.6
75
173
RK320
NOMESCO Finland
NA
6.3
20.6
55
89
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.0
20.6
124
429
WW500
NOMESCO Finland
Blood transfusion
2.7
20.5
140
525
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
6.0
20.5
57
97
L04AB01
ATC
etanercept; parenteral
6.4
20.5
54
86
J94.1
ICD-10 Finland
Fibrothorax
41.9
20.4
25
6
D07AB08
ATC
desonide; topical
1.9
20.4
300
1617
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.1
20.2
250
1263
N18.8
ICD-10 Finland
Other chronic renal failure
3.1
20.1
115
385
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
7.8
20.0
46
60
R29
ICPC
Respiratory symptom/complaint other
2.4
20.0
173
741
H25.1
ICD-10 Finland
Senile nuclear cataract
1.5
20.0
957
7155
RS123
NOMESCO Finland
NA
23.5
19.9
28
12
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
5.3
19.9
61
117
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.8
19.9
127
457
N05BA04
ATC
oxazepam; oral
1.6
19.9
652
4479
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.0
19.8
265
1378
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.4
19.7
170
725
1CX01
NOMESCO Finland
NA
105.6
19.6
21
*
A31.0
ICD-10 Finland
Pulmonary mycobacterial infection
201.0
19.6
20
*
3A006
NOMESCO Finland
NA
201.0
19.6
20
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.6
19.6
151
608
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.5
19.5
688
4803
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.4
19.5
166
703
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
19.4
313
1744
JN3AD
NOMESCO Finland
Abdominal CT examination
2.1
19.4
231
1148
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.9
19.4
119
418
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
19.2
697
4898
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
18.3
19.1
29
16
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.7
18.9
134
515
207
Kela drug reimbursment
Chronic arrhythmias
1.6
18.8
528
3485
J02AC03
ATC
voriconazole; systemic
28.0
18.7
25
9
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.7
18.6
415
2570
M33.2
ICD-10 Finland
Polymyositis
20.9
18.6
27
13
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
190.9
18.5
19
*
C10AA03
ATC
pravastatin; oral
1.9
18.5
275
1488
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
18.5
753
5424
N06AA09
ATC
amitriptyline; systemic
1.9
18.5
281
1535
B01AF02
ATC
apixaban; oral
1.8
18.5
342
1997
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.2
18.4
191
892
E000003
ATC
NA
2.6
18.3
133
518
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.8
18.2
321
1846
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.8
18.2
338
1976
M05BB03
ATC
alendronic acid and colecalciferol; oral
3.3
18.2
92
283
GD1UN
NOMESCO Finland
Lung circulation SPECT
8.6
18.1
39
46
D86.2
ICD-10 Finland
Sarcoidosis of lung with sarcoidosis of lymph nodes
7.8
18.0
41
53
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
18.0
917
6914
R60.0
ICD-10 Finland
Localized oedema
1.8
18.0
331
1930
R05FA02
ATC
opium derivatives and expectorants; systemic
1.4
18.0
1087
8469
RK110
NOMESCO Finland
NA
6.3
17.7
47
76
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
3.4
17.6
86
258
N06AB04
ATC
citalopram; systemic
1.6
17.5
535
3597
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
3.9
17.5
73
192
1XC02
NOMESCO Finland
NA
8.0
17.5
39
49
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
17.4
307
1762
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
13.1
17.4
30
23
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.1
17.4
203
1000
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.8
17.4
113
413
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
17.3
1107
8699
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.9
17.3
258
1401
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.9
17.1
264
1446
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
12.6
17.1
30
24
GD2SN
NOMESCO Finland
Lung ventilation SPECT
7.7
17.1
39
51
WZA10
NOMESCO Finland
Long statement of health and health related matters
5.0
17.0
54
109
A01AB04
ATC
amphotericin B; local oral
2.3
17.0
158
702
J94.8
ICD-10 Finland
Other specified pleural conditions
4.0
17.0
68
173
1240
FHL
Bronchoscopy
4.6
17.0
59
131
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.1
16.9
201
996
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
3.5
16.9
78
224
XQ800
NOMESCO Finland
Prick test
2.3
16.9
158
705
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
4.7
16.8
57
123
N05BA01
ATC
diazepam; systemic, rectal
1.7
16.8
353
2144
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
4.3
16.8
62
146
B01AC04
ATC
clopidogrel; oral
1.5
16.8
561
3853
SPAT1260
SPAT
Consultation of another employee
1.6
16.8
500
3342
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
4.9
16.7
54
111
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
15.1
16.6
27
18
J99.0
ICD-10 Finland
Rheumatoid lung disease
90.5
16.6
18
*
S18
ICPC
Laceration/cut
1.4
16.5
1226
9868
5169X
ICD-9 Finland
Other alveolar and parietoalveolar pneumopathy, Unspecified alveolar and parietoalveolar pneumopathy
170.7
16.5
17
*
J01GB01
ATC
tobramycin; inhalant, parenteral
170.7
16.5
17
*
N05CD07
ATC
temazepam; oral
1.7
16.5
404
2562
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
27.7
16.5
22
8
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
4.6
16.5
57
126
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
7.3
16.5
39
54
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
3.7
16.4
71
193
318
Kela drug reimbursment
Teriparatide
10.8
16.4
31
29
M80.9
ICD-10 Finland
Unspecified osteoporosis with pathological fracture
3.5
16.4
76
219
201
Kela drug reimbursment
Chronic cardiac insufficiency
2.1
16.4
188
918
XF404
NOMESCO Finland
Ambulatory ECG
1.8
16.3
290
1671
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
3.9
16.3
66
170
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.1
16.3
89
291
TKC20
NOMESCO Finland
Catheterisation of bladder
1.9
16.2
232
1241
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.2
16.2
166
774
M34.1
ICD-10 Finland
CR(E)ST syndrome
9.8
16.1
32
33
J42
ICD-10 Finland
Unspecified chronic bronchitis
4.9
16.1
52
107
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.4
16.1
77
228
XF402
NOMESCO Finland
ECG with work load test
1.7
16.1
351
2157
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
2.8
16.0
105
386
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.0
16.0
216
1126
M25.5
ICD-10 Finland
Pain in joint
1.5
16.0
667
4806
L03AA02
ATC
filgrastim; parenteral
3.1
16.0
88
289
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
7.2
16.0
38
53
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.2
16.0
84
267
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.5
15.9
125
509
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.8
15.9
106
391
Z71.8
ICD-10 Finland
Other specified counselling
1.5
15.9
555
3848
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.0
15.9
196
989
81
HP
Angiography of the heart and coronary arteries
1.8
15.8
268
1517
SPAT1060
SPAT
Administration of oxygen
14.5
15.8
26
18
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.0
15.8
93
320
L04AA24
ATC
abatacept; parenteral
15.7
15.7
25
16
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.1
15.7
188
938
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.4
15.6
130
548
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
3.7
15.6
67
182
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
5.4
15.5
46
86
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.9
15.5
232
1260
M05.1
ICD-10 Finland
Rheumatoid lung disease
160.6
15.5
16
*
RS221
NOMESCO Finland
NA
4.7
15.5
52
112
N06AX16
ATC
venlafaxine; oral
1.8
15.4
263
1493
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.6
15.4
70
199
J01FA01
ATC
erythromycin; systemic
1.8
15.4
296
1747
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.2
15.4
163
771
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
4.5
15.3
54
122
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
15.3
539
3742
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.4
15.3
133
571
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.7
15.3
309
1852
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
9.2
15.1
31
34
UDM02
NOMESCO Finland
Sinoscopy
4.1
15.1
59
147
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
6.0
15.1
41
69
M31.9
ICD-10 Finland
Necrotizing vasculopathy, unspecified
23.5
15.1
21
9
ZY010
NOMESCO Finland
Hospital outpatient
2.7
15.1
106
407
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
15.0
695
5112
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.4
15.0
132
572
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.5
15.0
672
4910
E000002
ATC
NA
1.8
14.9
275
1602
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
14.9
231
1270
R2110
NOMESCO Finland
Giving the first information
2.1
14.9
167
810
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
3.3
14.9
74
226
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
3.5
14.9
69
200
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.9
14.8
232
1280
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.0
14.8
192
987
A02BA03
ATC
famotidine; systemic
2.2
14.8
149
689
J11.1
ICD-10 Finland
Influenza with other respiratory manifestations, virus not identified
6.0
14.8
40
67
6BA02
NOMESCO Finland
NA
31.8
14.8
19
6
FXD00
NOMESCO Finland
Use of ECHLA without concurrent surgical procedure
56.9
14.8
17
*
RS230
NOMESCO Finland
NA
9.2
14.7
30
33
J98.4
ICD-10 Finland
Other disorders of lung
21.1
14.6
21
10
ZX197
NOMESCO Finland
NA
+∞
14.6
14
*
AK3
HP
BLTX (both lung transplants)
+∞
14.6
14
*
J17.1*B25.0
ICD-10 Finland
Cytomegaloviral pneumonitis
+∞
14.6
14
*
J15.1
ICD-10 Finland
Pneumonia due to Pseudomonas
+∞
14.6
14
*
J99.1*M33.2
ICD-10 Finland
Respiratory disorders in polymyositis
+∞
14.6
14
*
J01.1
ICD-10 Finland
Acute frontal sinusitis
7.7
14.6
33
43
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
2.8
14.5
95
350
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
14.5
1065
8513
B59
ICD-10 Finland
Pneumocystosis
150.6
14.5
15
*
M31.3
ICD-10 Finland
Wegener granulomatosis
10.9
14.5
27
25
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
14.5
460
3115
J01DA06
ATC
[U] cefuroxime; systemic
1.6
14.4
365
2335
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.3
14.3
72
222
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.0
14.3
195
1024
R11
ICD-10 Finland
Nausea and vomiting
1.9
14.3
204
1088
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.8
14.2
92
336
H05AA02
ATC
teriparatide; parenteral
10.5
14.2
27
26
M01AH02
ATC
rofecoxib; oral
1.6
14.2
385
2508
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
14.1
459
3122
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.3
14.0
131
585
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
7.2
14.0
33
46
R04.0
ICD-10 Finland
Epistaxis
1.8
14.0
234
1320
ZX100
NOMESCO Finland
Oral
3.9
13.9
57
149
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
13.9
1792
15582
M02AA07
ATC
piroxicam; topical
1.4
13.9
1054
8452
R13
ICD-10 Finland
Dysphagia
1.9
13.9
193
1020
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.1
13.8
75
245
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
7.8
13.8
31
40
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.3
13.8
134
608
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.8
13.8
266
1571
A01
ICPC
Pain general/multiple sites
1.9
13.8
204
1103
D07AA02
ATC
hydrocortisone; topical
1.7
13.8
322
2014
UDC00
NOMESCO Finland
Ear microscopy
1.9
13.7
208
1135
R4120
NOMESCO Finland
Occupational therapy
2.0
13.7
174
889
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
3.3
13.7
68
208
-1
NOMESCO Finland
NA
1.4
13.7
742
5612
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.5
13.7
62
177
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.8
13.6
233
1326
D07XC01
ATC
betamethasone, combinations; topical
1.6
13.6
341
2176
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.9
13.6
83
291
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.4
13.6
113
476
E84.9
ICD-10 Finland
Cystic fibrosis, unspecified
+∞
13.5
13
*
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.2
13.5
132
602
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
4.5
13.5
47
106
C07AB02
ATC
metoprolol; systemic
1.4
13.4
694
5202
UJD02
NOMESCO Finland
Gastroscopy
2.1
13.4
155
761
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
2.0
13.4
171
877
M33.9
ICD-10 Finland
Dermatopolymyositis, unspecified
25.8
13.3
18
7
GX2C5
NOMESCO Finland
Short-lasting oximetry
18.3
13.3
20
11
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
18.3
13.3
20
11
TFP20
NOMESCO Finland
Cardiodefibrillation
1.8
13.3
247
1443
J93.8
ICD-10 Finland
Other pneumothorax
7.7
13.3
30
39
TNB11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in shoulder joint
7.0
13.3
32
46
M03BX02
ATC
tizanidine; oral
1.3
13.3
1482
12583
SPAT1059
SPAT
Spirometry at the office
2.1
13.3
150
731
WX730
NOMESCO Finland
Conventional respirator
3.7
13.3
57
156
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
13.2
298
1844
A10AE04
ATC
insulin glargine; parenteral
1.7
13.2
256
1513
RS220
NOMESCO Finland
NA
4.6
13.2
45
99
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
13.8
13.2
22
16
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
4.5
13.2
46
104
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
13.1
491
3447
B34.9
ICD-10 Finland
Viral infection, unspecified
3.5
13.1
60
173
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
12.2
13.1
23
19
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
13.1
1218
10065
J01DA08
ATC
[U] cefaclor; oral
1.9
13.0
198
1083
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
13.0
432
2953
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
28.4
12.9
17
6
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
6.7
12.9
32
48
TGD00
NOMESCO Finland
Needle biopsy of lung
7.4
12.9
30
41
N19
ICD-10 Finland
Unspecified kidney failure
2.3
12.9
120
535
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.9
12.8
79
280
H04.10
ICD-10 Finland
Dry eye syndrome
1.8
12.7
238
1393
R51.80
ICD-10 Finland
Headache
1.7
12.7
288
1783
S22.3
ICD-10 Finland
Fracture of rib
1.9
12.7
190
1031
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
5.0
12.7
40
81
R07.3
ICD-10 Finland
Other chest pain
1.7
12.7
253
1508
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
6.3
12.7
33
53
Z57.2
ICD-10 Finland
Occupational exposure to dust
9.0
12.7
26
29
C10AA01
ATC
simvastatin; oral
1.3
12.7
1479
12608
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
12.6
407
2761
K29.3
ICD-10 Finland
Chronic superficial gastritis
2.4
12.6
105
444
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.6
12.6
90
348
J21.9
ICD-10 Finland
Acute bronchiolitis, unspecified
70.1
12.6
14
*
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.2
12.6
124
570
WX720
NOMESCO Finland
Own respiration
2.3
12.6
119
537
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.6
12.5
388
2608
304
Kela drug reimbursment
Dornase alfa
+∞
12.5
12
*
J01XB01
ATC
colistin; inhalant, parenteral
+∞
12.5
12
*
Z94.3
ICD-10 Finland
Heart and lungs transplant status
+∞
12.5
12
*
2770A
ICD-9 Finland
Other and unspecified disorders of metabolism, Cystic fibrosis
+∞
12.5
12
*
R05CB13
ATC
dornase alfa (desoxyribonuclease); inhalant
+∞
12.5
12
*
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.1
12.5
68
224
J31.0
ICD-10 Finland
Chronic rhinitis
1.9
12.4
176
938
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
130.4
12.4
13
*
3AC01
NOMESCO Finland
NA
5.0
12.4
39
79
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
12.4
1137
9350
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.6
12.4
350
2301
B03XA02
ATC
darbepoetin alfa; parenteral
3.4
12.4
59
176
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
3.8
12.4
51
135
D70.82
ICD-10 Finland
Drug-induced neutropenia
4.0
12.3
48
121
ZX121
NOMESCO Finland
Central venous catheter
11.6
12.3
22
19
UGC02
NOMESCO Finland
Rigid bronchoscopy
14.4
12.2
20
14
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
6.2
12.2
32
52
M80.8
ICD-10 Finland
Other osteoporosis with pathological fracture
9.0
12.2
25
28
M34.8
ICD-10 Finland
Other forms of systemic sclerosis
37.7
12.2
15
*
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
37.7
12.2
15
*
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
3.8
12.2
51
137
B01AB10
ATC
tinzaparin; parenteral
1.8
12.1
193
1072
M05BA06
ATC
ibandronic acid; systemic
3.0
12.1
69
232
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
3.5
12.1
56
164
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
2.0
12.0
154
790
J01DC02
ATC
cefuroxime; systemic
2.2
12.0
125
590
RK250
NOMESCO Finland
NA
7.2
12.0
28
39
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2.2
11.9
116
528
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
5.2
11.9
36
70
J99.1*M35.0
ICD-10 Finland
Respiratory disorders in sicca syndrome [Sjögren]
46.8
11.9
14
*
NDG30
NOMESCO Finland
Fusion of wrist, total
7.0
11.8
28
40
J32.4
ICD-10 Finland
Chronic pansinusitis
4.4
11.8
41
93
XX7LW
NOMESCO Finland
NA
14.7
11.8
19
13
B01AB04
ATC
dalteparin; parenteral
2.0
11.8
148
755
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
8.4
11.8
25
30
R03AC18
ATC
indacaterol; inhalant
5.4
11.8
34
63
C08CA01
ATC
amlodipine; oral
1.3
11.7
1124
9283
R06AX27
ATC
desloratadine; oral
1.4
11.7
516
3740
M01AB55
ATC
diclofenac, combinations; oral
1.8
11.7
209
1209
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.6
11.6
85
336
A07AA09
ATC
vancomycin; oral
4.3
11.6
42
99
291
Kela drug reimbursment
Tofacitinib
12.6
11.6
20
16
A11CC03
ATC
alfacalcidol; systemic
3.0
11.6
67
229
M34.0
ICD-10 Finland
Progressive systemic sclerosis
19.0
11.6
17
9
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
11.1
11.5
21
19
K77
ICPC
Heart failure
2.7
11.5
76
283
WNF00
NOMESCO Finland
Infection source and contact determination
9.3
11.5
23
25
47099
ICD-8 Finland
Influenza, unqualified
+∞
11.5
11
*
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
+∞
11.5
11
*
4630A
ICD-9 Finland
Acute tonsillitis[TONSILLITIS ACUTA]
+∞
11.5
11
*
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
5.5
11.5
33
61
ZX114
NOMESCO Finland
Intramuscular
3.8
11.4
47
125
Z49.1
ICD-10 Finland
Extracorporeal dialysis
4.1
11.4
43
106
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
4.1
11.4
43
106
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.6
11.4
284
1809
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.6
11.2
295
1900
GX2D5
NOMESCO Finland
Sleep oximetry
9.6
11.2
22
23
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
2.8
11.2
70
252
XX4AW
NOMESCO Finland
NA
17.1
11.2
17
10
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.7
11.1
248
1529
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
25.1
11.1
15
6
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
11.1
481
3472
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.6
11.1
78
302
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.0
11.1
145
752
K02.1
ICD-10 Finland
Caries of dentine
1.3
11.1
1310
11117
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.3
11.0
103
463
H03AA01
ATC
levothyroxine sodium; systemic
1.4
11.0
566
4219
R09
ICPC
Sinus symptom/complaint
2.0
11.0
131
652
I20.90
ICD-10 Finland
Angina pectoris, unspecified
2.1
11.0
129
641
D07CC01
ATC
betamethasone and antibiotics; topical
1.6
11.0
309
2026
WX402
NOMESCO Finland
General anaesthesia
1.5
11.0
389
2693
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
11.0
471
3395
J67.0
ICD-10 Finland
Farmer lung
13.9
11.0
18
13
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
3.1
10.9
57
183
J37.0
ICD-10 Finland
Chronic laryngitis
2.4
10.9
88
368
B44.1
ICD-10 Finland
Other pulmonary aspergillosis
43.4
10.9
13
*
A04AA01
ATC
ondansetron; systemic, rectal
1.9
10.9
161
873
L40.5
ICD-10 Finland
Arthropathic psoriasis
3.3
10.8
52
157
R05CB01
ATC
acetylcysteine; inhalant, oral
3.0
10.8
60
201
R42
ICD-10 Finland
Dizziness and giddiness
1.4
10.8
599
4527
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.7
10.8
72
271
I20.09
ICD-10 Finland
Unstable angina
1.8
10.7
188
1078
M33.1
ICD-10 Finland
Other dermatomyositis
17.8
10.7
16
9
D11
ICPC
Diarrhoea
1.7
10.7
214
1280
A02BA04
ATC
nizatidine; systemic
1.7
10.7
247
1539
F43.29
ICD-10 Finland
Adaptation disorder UNS
4.1
10.7
40
98
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
21.5
10.7
15
7
K07
ICPC
Swollen ankles/oedema
2.0
10.6
137
709
Z50.1
ICD-10 Finland
Other physical therapy
1.9
10.5
153
825
R01BA52
ATC
pseudoephedrine, combinations; oral
1.4
10.5
683
5295
RD210
NOMESCO Finland
NA
3.7
10.5
45
124
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.3
10.5
1053
8718
L04AB05
ATC
certolizumab pegol; parenteral
11.2
10.5
19
17
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
10.5
202
1195
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
10.5
1494
12960
R06AX22
ATC
ebastine; oral
1.5
10.5
348
2375
D07BC01
ATC
betamethasone and antiseptics; topical
1.6
10.5
313
2085
M48.0
ICD-10 Finland
Spinal stenosis
1.5
10.5
372
2577
E66.01
ICD-10 Finland
Obesity due to excess calories
1.9
10.4
144
762
D72.1
ICD-10 Finland
Eosinophilia
7.3
10.4
24
33
E84.1
ICD-10 Finland
Cystic fibrosis with intestinal manifestations
+∞
10.4
10
*
FXF00
NOMESCO Finland
Decannulation after ECHLA or ECLA
+∞
10.4
10
*
J17.3
ICD-10 Finland
Pneumonia in parasitic diseases
+∞
10.4
10
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
4.0
10.4
40
101
R03BB06
ATC
glycopyrronium bromide; inhalant
6.8
10.4
25
37
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.6
10.4
75
297
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
3.4
10.3
49
147
ZYY98
NOMESCO Finland
Missed treatment contact, no notification given by patient
16.1
10.3
16
10
M35.1
ICD-10 Finland
Other overlap syndromes
8.2
10.3
22
27
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.2
10.3
105
492
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
4.0
10.3
40
102
SPAT1229
SPAT
Assessment of need for aid
1.7
10.3
233
1445
WVA40
NOMESCO Finland
Initiation and monitoring of intravenous hydration
3.6
10.3
44
122
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
2.3
10.2
91
398
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
4.7
10.2
33
70
I27.0
ICD-10 Finland
Primary pulmonary hypertension
13.1
10.1
17
13
R01AD01
ATC
beclometasone; nasal
1.5
10.1
345
2365
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
5.0
10.1
31
62
A12BA01
ATC
potassium chloride; oral
1.9
10.1
151
820
N06AX21
ATC
duloxetine; oral
1.7
10.1
210
1269
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
4.4
10.1
35
80
R24
ICPC
Haemoptysis
5.4
10.1
29
54
NHQ40
NOMESCO Finland
Amputation of toe
3.0
10.1
58
198
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.6
10.1
43
119
R01
ICPC
Pain respiratory system
3.7
10.1
42
114
C08CA02
ATC
felodipine; oral
1.5
10.0
308
2065
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
8.4
10.0
21
25
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
4.1
10.0
37
90
ZY000
NOMESCO Finland
Hospital inpatient
5.0
10.0
31
63
EB1WA
NOMESCO Finland
NA
6.4
10.0
25
39
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
1.7
10.0
194
1152
M35.8
ICD-10 Finland
Other specified systemic involvement of connective tissue
14.6
10.0
16
11
L01BB05
ATC
fludarabine; systemic
40.2
10.0
12
*
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
5.3
9.9
29
55
E000006
ATC
NA
1.8
9.9
172
983
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
3.4
9.9
46
136
TGA30
NOMESCO Finland
Thoracocentesis
4.7
9.9
32
68
GDC00
NOMESCO Finland
Lobectomy of lung
4.7
9.9
32
68
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
3.0
9.9
57
195
XX2XT
NOMESCO Finland
Other injection with other radiological guidance
7.6
9.9
22
29
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
2.5
9.9
77
316
R03BB05
ATC
aclidinium bromide; inhalant
12.2
9.8
17
14
M06
ICD-10 Finland
Other rheumatoid arthritis
5.0
9.8
30
60
M01AH01
ATC
celecoxib; oral (coxibs)
1.4
9.8
472
3471
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.0
9.8
54
181
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
2.1
9.8
104
495
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
2.7
9.8
64
239
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
9.8
1029
8554
N07BA03
ATC
varenicline; oral
2.2
9.8
97
449
J01.4
ICD-10 Finland
Acute pansinusitis
20.1
9.8
14
7
WX213
NOMESCO Finland
Lower leg blockade
5.4
9.8
28
52
R03BB07
ATC
umeclidinium bromide; inhalant
5.4
9.8
28
52
NG1DA
NOMESCO Finland
X-ray of knees
2.9
9.8
58
204
C08CA05
ATC
nifedipine; systemic
1.7
9.8
212
1301
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.7
9.7
183
1076
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.4
9.7
79
330
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
2.9
9.7
58
205
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.0
9.7
117
589
N30.0
ICD-10 Finland
Acute cystitis
1.5
9.7
315
2138
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
13.4
9.7
16
12
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
13.4
9.7
16
12
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.7
9.7
219
1359
C02KX04
ATC
macitentan; oral
55.1
9.6
11
*
FXE00
NOMESCO Finland
Use of ECLA
55.1
9.6
11
*
N30.2
ICD-10 Finland
Other chronic cystitis
4.4
9.6
33
75
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
1.7
9.6
183
1081
N17.8
ICD-10 Finland
Other acute renal failure
3.7
9.6
40
109
I84.1
ICD-10 Finland
Internal hemorrhoids with other complications
2.5
9.5
70
280
L04AA29
ATC
tofacitinib; oral
11.4
9.5
17
15
XJC00
NOMESCO Finland
Oesophageal manometry
8.4
9.5
20
24
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
15.0
9.5
15
10
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
4.4
9.5
33
76
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
3.8
9.5
38
100
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.9
9.5
134
716
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
3.7
9.5
39
105
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.8
9.5
57
203
R04
ICPC
Breathing problem other
2.3
9.5
84
370
I26
ICD-10 Finland
Pulmonary embolism
4.2
9.4
34
81
R49.01
ICD-10 Finland
Functional dysphonia
2.5
9.4
74
304
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.0
9.4
124
647
RF210
NOMESCO Finland
NA
2.5
9.4
69
276
SAA04
NOMESCO Finland
Special inverstigation of mouth
2.0
9.4
121
623
H26.3
ICD-10 Finland
Drug-induced cataract
6.6
9.4
23
35
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.4
9.4
598
4613
JN4CD
NOMESCO Finland
Very extensive body CT
2.0
9.4
123
637
J98.2
ICD-10 Finland
Interstitial emphysema
30.1
9.4
12
*
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
3.6
9.4
40
111
4618A
ICD-9 Finland
Acute sinusitis, Other acute sinusitis
+∞
9.4
9
*
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
+∞
9.4
9
*
B37.0
ICD-10 Finland
Candidal stomatitis
4.2
9.3
34
82
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
8.0
9.3
20
25
I95.9
ICD-10 Finland
Hypotension, unspecified
3.3
9.3
45
138
N05BA06
ATC
lorazepam; systemic, sublingual
1.9
9.3
133
715
EBA10
NOMESCO Finland
Surgical removal of tooth
1.6
9.3
214
1336
L95
ICPC
Osteoporosis
2.2
9.3
88
400
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.8
9.3
144
795
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
2.9
9.3
55
194
L01CB
ATC
Podophyllotoxin derivatives
10.7
9.3
17
16
J98.9
ICD-10 Finland
Respiratory disorder, unspecified
9.5
9.3
18
19
A07EC02
ATC
mesalazine; oral, rectal
1.9
9.2
124
650
S02CA02
ATC
flumetasone and antiinfectives; otic
1.8
9.2
151
848
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
7.3
9.2
21
29
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
4.4
9.2
32
74
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
4.6
9.2
30
65
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.2
9.2
92
428
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
9.2
236
1514
XF622
NOMESCO Finland
Measurement of minute volume of heart
7.7
9.1
20
26
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.6
9.1
225
1431
N03AE01
ATC
clonazepam; systemic
1.9
9.1
131
706
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
2.6
9.1
65
254
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
9.1
413
3006
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.8
9.1
150
847
L04AB06
ATC
golimumab; parenteral
6.2
9.1
23
37
J93.9
ICD-10 Finland
Pneumothorax, unspecified
6.2
9.1
23
37
J32.1
ICD-10 Finland
Chronic frontal sinusitis
11.5
9.1
16
14
L04AA17
ATC
[U] adalimumab; parenteral
8.3
9.0
19
23
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
8.3
9.0
19
23
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
9.0
1232
10566
S22.2
ICD-10 Finland
Fracture of sternum
5.6
9.0
25
45
KMAK
NOMESCO Finland
NA
1.3
9.0
1181
10079
49099
ICD-8 Finland
Bronchitis, unspecified
4.0
9.0
34
85
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
4.4
9.0
31
71
B90.9
ICD-10 Finland
Sequelae of respiratory and unspecified tuberculosis
7.0
9.0
21
30
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.5
9.0
290
1968
GD1LA
NOMESCO Finland
GD
3.0
9.0
50
170
212
Kela drug reimbursment
Gout
2.3
8.9
77
333
J85.1
ICD-10 Finland
Abscess of lung with pneumonia
18.6
8.9
13
7
T86.8
ICD-10 Finland
Failure and rejection of other transplanted organs and tissues
18.6
8.9
13
7
R78
ICPC
Acute bronchitis/bronchiolitis
2.7
8.9
58
217
4040
NOMESCO Finland
NA
24.1
8.9
12
5
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
5.2
8.9
26
50
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
8.9
313
2161
M01AB05
ATC
diclofenac; systemic, rectal
1.2
8.9
1754
15702
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
3.4
8.9
41
122
WX740
NOMESCO Finland
Nitrogen oxide therapy
12.5
8.9
15
12
ED1AA
NOMESCO Finland
Mandipular X-ray examination
4.8
8.8
28
59
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
3.9
8.8
34
87
N05AH04
ATC
quetiapine; oral
1.5
8.8
305
2101
R03DC01
ATC
zafirlukast; oral
3.1
8.8
46
150
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
8.6
8.8
18
21
R94.2
ICD-10 Finland
Abnormal results of pulmonary function studies
4.6
8.8
29
64
M70.2
ICD-10 Finland
Olecranon bursitis
2.1
8.7
96
465
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
8.7
365
2611
S01GX01
ATC
cromoglicic acid; ophthalmic
1.4
8.7
369
2649
C01BD01
ATC
amiodarone; systemic
2.2
8.7
87
407
L03
ICPC
Low back symptom/complaint
1.4
8.7
556
4291
5163A
ICD-9 Finland
Other alveolar and parietoalveolar pneumopathy, Idiopathic fibrosing alveolitis
50.1
8.7
10
*
J21.90
ICD-10 Finland
Acute obstructive bronchitis in children
50.1
8.7
10
*
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.3
8.6
73
315
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
3.4
8.6
39
114
M01CB03
ATC
auranofin; oral
4.1
8.6
32
79
J03.0
ICD-10 Finland
Streptococcal tonsillitis
4.1
8.6
32
79
J01EA01
ATC
trimethoprim; systemic
1.3
8.6
625
4918
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
2.2
8.6
84
389
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
4.6
8.6
28
61
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
8.6
827
6776
49300
ICD-8 Finland
Asthma, bronchiale
2.6
8.6
59
228
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
2.0
8.6
102
513
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.9
8.5
50
175
K59.1
ICD-10 Finland
Functional diarrhoea
1.9
8.5
127
694
R06AX13
ATC
loratadine; oral
1.5
8.5
283
1928
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.8
8.5
51
182
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.6
8.5
223
1437
TNG10
NOMESCO Finland
Puncture of knee
3.7
8.5
35
95
132
Kela drug reimbursment
Sarcoidosis
4.9
8.5
26
53
A01AB10
ATC
natamycin; local oral
2.2
8.5
78
352
A91
ICPC
Abnormal result investigation NOS
1.9
8.5
116
615
D68.8
ICD-10 Finland
Other specified coagulation defects
4.5
8.5
28
62
SPAT1310
SPAT
Counselling related to known health issue
1.3
8.4
826
6779
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
6.0
8.4
22
37
D83.0
ICD-10 Finland
Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
90.2
8.4
9
*
M35.3
ICD-10 Finland
Polymyalgia rheumatica
1.8
8.4
129
710
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
8.4
258
1729
D02AE01
ATC
carbamide; topical
1.7
8.4
158
929
Z02.7
ICD-10 Finland
Issue of medical certificate
1.8
8.4
146
841
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.2
8.4
1298
11272
48601
ICD-8 Finland
More specifically, unspecified pneumonia and the pleural irritation caused by it
+∞
8.3
8
*
4829X
ICD-9 Finland
Other bacterial pneumonia, Bacterial pneumonia unspecified
+∞
8.3
8
*
E84.8
ICD-10 Finland
Cystic fibrosis with other manifestations
+∞
8.3
8
*
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
8.3
1683
15053
R63.4
ICD-10 Finland
Abnormal weight loss
2.0
8.3
102
517
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
3.8
8.3
33
87
D01AC02
ATC
miconazole; topical
1.6
8.3
221
1432
A29
ICPC
General symptom/complaint other
1.5
8.3
286
1967
A15.0
ICD-10 Finland
Tuberculosis of lung, confirmed by sputum microscopy with or without culture
8.5
8.3
17
20
TGW99
NOMESCO Finland
Other minor procedure in thoracic surgery
8.5
8.3
17
20
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.6
8.3
236
1554
K92.1
ICD-10 Finland
Melaena
1.7
8.3
154
906
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
2.5
8.2
60
238
R06.8
ICD-10 Finland
Other and unspecified abnormalities of breathing
3.1
8.2
42
135
SPAT1211
SPAT
Application of soft bandage
1.6
8.2
234
1540
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
8.2
1839
16622
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
2.4
8.2
67
284
M79.1
ICD-10 Finland
Myalgia
1.5
8.2
265
1796
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
2.5
8.2
60
239
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
4.4
8.2
28
64
Z94.0
ICD-10 Finland
Kidney transplant status
4.4
8.2
28
64
I21.40
ICD-10 Finland
Acute subendocardial infarction no detected stenosis of the coronary artery
2.1
8.2
90
436
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
1.7
8.2
167
1007
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
3.8
8.2
33
88
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
1.9
8.2
116
623
J01CA08
ATC
pivmecillinam; oral
1.3
8.2
818
6729
R06AE09
ATC
levocetirizine; oral
1.5
8.2
276
1891
N06AB03
ATC
fluoxetine; oral
1.5
8.1
261
1768
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.4
8.1
66
279
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
2.4
8.1
66
279
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
4.7
8.1
26
56
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
33.4
8.1
10
*
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
33.4
8.1
10
*
J43.1
ICD-10 Finland
Panlobular emphysema
33.4
8.1
10
*
RS310
NOMESCO Finland
NA
17.2
8.1
12
7
G44.2
ICD-10 Finland
Tension-type headache
1.5
8.1
247
1656
N05AA02
ATC
levomepromazine; systemic
2.1
8.1
84
398
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.3
8.1
71
311
C83.1
ICD-10 Finland
Mantle cell lymphoma
6.8
8.0
19
28
M80.0
ICD-10 Finland
Postmenopausal osteoporosis with pathological fracture
2.6
8.0
56
219
V03AE01
ATC
polystyrene sulfonate; oral
3.1
8.0
42
138
WVA20
NOMESCO Finland
Medicine administration
2.5
8.0
62
255
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
22.1
8.0
11
5
J21.99
ICD-10 Finland
Acute bronchiolitis, unspecified
22.1
8.0
11
5
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
4.3
8.0
28
66
RF220
NOMESCO Finland
NA
3.0
8.0
43
144
J98.6
ICD-10 Finland
Disorders of diaphragm
5.5
8.0
22
40
J01XX08
ATC
linezolid; systemic
5.5
8.0
22
40
E66.8
ICD-10 Finland
Other obesity
2.1
8.0
89
438
D20
ICPC
Mouth/tongue/lip symptom/complaint
2.0
7.9
99
505
UKC02
NOMESCO Finland
Cystoscopy
1.3
7.9
512
3952
-44
ICPC
Preventive immunization/medic
1.5
7.9
250
1687
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
4.0
7.9
30
76
HA1AA
NOMESCO Finland
X-ray mammography
1.7
7.9
154
916
K29.7
ICD-10 Finland
Gastritis, unspecified
2.0
7.9
99
506
XX1VW
NOMESCO Finland
Written report from radiologist
4.7
7.9
25
53
R60.9
ICD-10 Finland
Oedema, unspecified
1.9
7.9
117
637
A10AE05
ATC
insulin detemir; parenteral
1.8
7.9
129
730
RK310
NOMESCO Finland
NA
13.0
7.9
13
10
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.0
7.9
92
459
X58
ICD-10 Finland
Exposure to other specified factors
1.5
7.8
289
2016
D06BB04
ATC
podophyllotoxin; topical
2.3
7.8
71
319
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
6.1
7.8
20
33
XX1AW
NOMESCO Finland
Written report from X-ray examination without contrast peformed elsewhere
6.1
7.8
20
33
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
7.8
294
2063
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
3.1
7.7
39
125
11
HP
Coronary artery bypass surgery
2.0
7.7
91
455
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.5
7.7
58
237
T90
ICPC
Diabetes non-insulin dependent
1.3
7.7
653
5248
L17
ICPC
Foot/toe symptom/complaint
1.3
7.7
629
5031
A16.0
ICD-10 Finland
Tuberculosis of lung, bacteriologically and histologically negative
15.0
7.7
12
8
B00.2
ICD-10 Finland
Herpesviral gingivostomatitis and pharyngotonsillitis
15.0
7.7
12
8
EBA00
NOMESCO Finland
Extraction of tooth
1.3
7.7
772
6345
WX204
NOMESCO Finland
Axillary plexus blockaced
2.2
7.7
75
349
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.7
7.7
155
934
M01AH05
ATC
etoricoxib; oral
1.2
7.7
1412
12463
A12AA04
ATC
calcium carbonate; oral
2.9
7.6
44
152
R4130
NOMESCO Finland
Speech therapy
2.4
7.6
63
269
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.4
7.6
419
3151
M01AE02
ATC
naproxen; oral, rectal
1.2
7.6
1381
12159
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.8
7.6
134
776
SPAT1301
SPAT
No procedures
1.3
7.6
865
7223
WX704
NOMESCO Finland
Intubation
1.7
7.6
163
1001
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
2.5
7.6
57
233
-34
ICPC
Blood test
2.2
7.6
74
344
F2682
NOMESCO Finland
NA
11.9
7.6
13
11
J70.4
ICD-10 Finland
Drug-induced interstitial lung disorders, unspecified
25.0
7.6
10
*
P03
ICPC
Feeling depressed
1.8
7.6
122
685
ZX140
NOMESCO Finland
Intra articular
4.5
7.5
25
56
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
3.9
7.5
29
75
NK5AT
NOMESCO Finland
Joint injection with ultrasound guidance not elsewhere classified
5.1
7.5
22
43
M01AX17
ATC
nimesulide; oral
1.3
7.5
658
5311
RK120
NOMESCO Finland
NA
6.2
7.5
19
31
R03AC19
ATC
olodaterol; inhalant
6.2
7.5
19
31
NF1AA
NOMESCO Finland
Hip X-ray examination
1.5
7.5
245
1664
A41.8
ICD-10 Finland
Other specified sepsis
2.8
7.5
44
156
SXC03
NOMESCO Finland
Other oral or dental procedure
3.6
7.4
31
86
N05CF02
ATC
zolpidem; oral
1.4
7.4
377
2797
R55
ICD-10 Finland
Syncope and collapse
1.4
7.4
306
2185
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.7
7.4
156
951
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.2
7.4
73
341
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.9
7.4
103
549
J85.2
ICD-10 Finland
Abscess of lung without pneumonia
13.4
7.4
12
9
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
2.1
7.4
75
355
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
5.3
7.4
21
40
W19
ICD-10 Finland
Unspecified fall
1.5
7.4
221
1474
C09CA01
ATC
losartan; oral
1.3
7.3
664
5380
K76.9
ICD-10 Finland
Liver disease, unspecified
3.0
7.3
40
136
WYA20
NOMESCO Finland
Home visit
2.7
7.3
48
182
J98.1
ICD-10 Finland
Pulmonary collapse
4.3
7.3
25
58
L29
ICPC
Musculoskeletal sympt/complt other
1.6
7.3
178
1131
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.1
7.3
81
395
WW300
NOMESCO Finland
Transfer of autologic stem cells
8.4
7.3
15
18
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.8
7.3
116
648
46209
ICD-8 Finland
Acute pharyngitis, Unspecified
+∞
7.3
7
*
J10
ICD-10 Finland
Influenza due to identified seasonal influenza virus
+∞
7.3
7
*
J16.8
ICD-10 Finland
Pneumonia due to other specified infectious organisms
+∞
7.3
7
*
B05XA03
ATC
sodium chloride; parenteral
+∞
7.3
7
*
3005
Kela drug reimbursment
Tofacitinib
10.9
7.3
13
12
Z94.1
ICD-10 Finland
Heart transplant status
10.9
7.3
13
12
K29.5
ICD-10 Finland
Chronic gastritis, unspecified
2.1
7.3
79
384
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
2.3
7.3
61
264
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
4.1
7.3
26
63
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.7
7.3
129
750
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
2.5
7.3
52
208
-69
ICPC
Other reason for encounter NEC
1.9
7.3
104
561
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
3.9
7.2
28
73
Z01.9
ICD-10 Finland
Special examination, unspecified
1.7
7.2
134
789
RS224
NOMESCO Finland
NA
6.2
7.2
18
29
K78
ICPC
Atrial fibrillation/flutter
1.5
7.2
243
1663
R03DX07
ATC
roflumilast; oral
15.8
7.2
11
7
R52.9
ICD-10 Finland
Pain, unspecified
1.6
7.2
183
1175
A11
ICPC
Chest pain NOS
1.6
7.2
195
1270
103
Kela drug reimbursment
Diabetes, insulin-treated
1.3
7.2
784
6506
RJ420
NOMESCO Finland
NA
7.3
7.2
16
22
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.7
7.1
138
820
C02KX01
ATC
bosentan; oral
30.1
7.1
9
*
J15
ICD-10 Finland
Bacterial pneumonia, not elsewhere classified
30.1
7.1
9
*
M31.0
ICD-10 Finland
Hypersensitivity angiitis
30.1
7.1
9
*
T92
ICPC
Gout
2.3
7.1
63
280
NDL52
NOMESCO Finland
Tenosynovectomy of hand
4.8
7.1
22
46
602
Kela drug reimbursment
Children's severe malnutrition
20.0
7.1
10
5
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.5
7.1
236
1611
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.7
7.1
148
901
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.9
7.1
97
516
D63.8
ICD-10 Finland
Anaemia in other chronic diseases classified elsewhere
6.6
7.1
17
26
Z01.2
ICD-10 Finland
Dental examination
1.3
7.1
882
7433
K08.3
ICD-10 Finland
Retained dental root
1.6
7.1
172
1092
TQW40
NOMESCO Finland
Remowal of suture of skin
1.6
7.1
164
1029
Z00.0
ICD-10 Finland
General medical examination
1.3
7.1
457
3530
WX320
NOMESCO Finland
Spinalanesthesy
1.3
7.0
596
4786
S20.2
ICD-10 Finland
Contusion of thorax
1.8
7.0
116
659
J93.0
ICD-10 Finland
Spontaneous tension pneumothorax
8.8
7.0
14
16
L95.8
ICD-10 Finland
Other vasculitis limited to skin
8.8
7.0
14
16
RJ412
NOMESCO Finland
NA
10.0
7.0
13
13
E66.00
ICD-10 Finland
Metabolic syndrome
1.8
7.0
112
630
RK220
NOMESCO Finland
NA
7.0
7.0
16
23
H01
ICPC
Ear pain/earache
1.5
7.0
196
1291
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.6
6.9
182
1179
I73.0
ICD-10 Finland
Raynaud syndrome
2.9
6.9
40
139
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.3
6.9
582
4665
XPX04
NOMESCO Finland
Angioscopy
6.3
6.9
17
27
SBA00
NOMESCO Finland
Microbiological examinations
2.3
6.9
61
270
M05BA01
ATC
etidronic acid; systemic
4.2
6.9
24
57
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
1.6
6.9
154
955
M31.7
ICD-10 Finland
Microscopic polyangiitis
13.8
6.9
11
8
M31.8
ICD-10 Finland
Other specified necrotizing vasculopathies
13.8
6.9
11
8
WX203
NOMESCO Finland
Infraclavicular plexus blockade
2.4
6.9
53
221
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
6.9
378
2843
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.6
6.9
46
178
K51.5
ICD-10 Finland
Left sided colitis
2.4
6.9
55
233
M10.0
ICD-10 Finland
Idiopathic gout
1.9
6.9
93
494
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
1.8
6.8
118
681
R03BC03
ATC
nedocromil; inhalant
1.6
6.8
160
1005
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
4.8
6.8
21
44
S29
ICPC
Skin symptom/complaint other
1.3
6.8
427
3281
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
2.9
6.8
39
135
WW409
NOMESCO Finland
Other aferesis
10.9
6.8
12
11
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
1.9
6.8
90
473
S02
ICPC
Pruritus
2.0
6.8
77
381
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
5.3
6.8
19
36
3A064
NOMESCO Finland
NA
5.6
6.7
18
32
8041/3-C34.3
ICD-O-3
Small cell carcinoma, NOS, of lower lobe, lung
16.7
6.7
10
6
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
3.0
6.7
36
122
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.5
6.7
221
1510
I20.89
ICD-10 Finland
Other angina pectoris unspecified coronary artery status
1.7
6.7
134
808
5110B
ICD-9 Finland
Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]
7.2
6.7
15
21
K51.8
ICD-10 Finland
Other ulcerative colitis
3.2
6.7
32
100
M09AA72
ATC
quinine, combinations with psycholeptics; systemic
1.8
6.7
107
602
M32
ICD-10 Finland
Systemic lupus erythematosus
22.5
6.7
9
*
GDB01
NOMESCO Finland
Thoracoscopic resection of bullae of lung
22.5
6.7
9
*
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
22.5
6.7
9
*
SPAT1097
SPAT
Recording of ECG
1.3
6.7
413
3165
B37.08
ICD-10 Finland
Other candidal stomatitis
3.9
6.7
25
64
J94.9
ICD-10 Finland
Pleural condition, unspecified
4.9
6.6
20
41
K90.3
ICD-10 Finland
Pancreatic steatorrhoea
4.9
6.6
20
41
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
3.3
6.6
31
95
I20.00
ICD-10 Finland
Unstable angina
1.8
6.6
105
589
ZXX03
NOMESCO Finland
Extent of procedure, 3 units
4.4
6.6
22
50
R35
ICD-10 Finland
Polyuria
1.6
6.6
174
1128
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.6
6.6
45
176
B07.9
ICD-10 Finland
Verruca simplex
2.0
6.6
74
365
Z31.5
ICD-10 Finland
Genetic counselling
2.0
6.6
76
378
R06.5
ICD-10 Finland
Mouth breathing
1.5
6.6
192
1275
R84
ICPC
Malignant neoplasm bronchus/lung
5.9
6.6
17
29
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
1.8
6.6
108
612
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.1
6.6
65
306
348
Kela drug reimbursment
Roflumilast
12.3
6.6
11
9
M05.3
ICD-10 Finland
Rheumatoid arthritis with involvement of other organs and systems
12.3
6.6
11
9
N06AB10
ATC
escitalopram; oral
1.4
6.6
345
2577
M00.9
ICD-10 Finland
Pyogenic arthritis, unspecified
2.9
6.6
36
124
L03AA13
ATC
pegfilgrastim; parenteral
2.0
6.5
76
382
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
3.0
6.5
34
113
C10AX09
ATC
ezetimibe; oral
1.4
6.5
290
2102
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
10.0
6.5
12
12
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.1
6.5
67
321
N05BA12
ATC
alprazolam; oral
1.5
6.5
213
1453
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
2.0
6.5
73
360
A07EA06
ATC
budesonide; oral, local oral
2.0
6.5
73
360
L04AA11
ATC
[U] etanercept; parenteral
6.8
6.5
15
22
J01MA01
ATC
ofloxacin; systemic
1.5
6.5
241
1685
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.6
6.5
145
900
K22.4
ICD-10 Finland
Dyskinesia of oesophagus
5.0
6.5
19
38
WZA90
NOMESCO Finland
Other doctors statement
1.3
6.5
498
3945
G53.0
ICD-10 Finland
Postzoster neuralgia
3.6
6.5
27
76
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.6
6.5
27
76
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
4.0
6.5
24
61
I25
ICD-10 Finland
Chronic ischaemic heart disease
1.6
6.4
153
967
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.3
6.4
30
92
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
3.3
6.4
30
92
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
5.7
6.4
17
30
J15.2
ICD-10 Finland
Pneumonia due to staphylococcus
70.0
6.4
7
*
GCA18
NOMESCO Finland
Bronchoscopic dilatation of bronchus
70.0
6.4
7
*
J99.1*M34.8
ICD-10 Finland
Respiratory disorders in systemic: sclerosis
70.0
6.4
7
*
M47.9
ICD-10 Finland
Spondylosis, unspecified
1.9
6.4
83
432
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.5
6.4
179
1178
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
3.2
6.4
31
98
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.4
6.4
299
2189
GDA97
NOMESCO Finland
Other thoracoscopic incision, excision of lesion or repair of lung
14.3
6.4
10
7
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
3.2
6.4
30
93
DHB20
NOMESCO Finland
Polypectomy of internal nose
2.8
6.3
37
131
A34
ICPC
General and Unspecified, Blood test
2.8
6.3
38
138
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.6
6.3
152
964
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.8
6.3
104
590
D02AX
ATC
Other emollients and protectives
2.0
6.3
74
372
L04AC07
ATC
tocilizumab; parenteral
6.5
6.3
15
23
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.6
6.3
137
846
N06AX26
ATC
vortioxetine; oral
1.9
6.3
89
482
N03AF01
ATC
carbamazepine; oral, rectal
1.7
6.3
120
714
RK290
NOMESCO Finland
NA
5.9
6.3
16
27
SPAT1251
SPAT
Organisation of medication
1.8
6.3
96
531
GDA21
NOMESCO Finland
Thoracoscopic excision of lesion of lung
9.3
6.3
12
13
SPAT1252
SPAT
Overall medication plan or its review
1.5
6.3
188
1257
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
4.6
6.3
20
44
D69.0
ICD-10 Finland
Allergic purpura
4.6
6.3
20
44
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
4.6
6.3
20
44
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
3.6
6.3
26
73
J01MA06
ATC
norfloxacin; oral
1.4
6.3
321
2387
D89.89
ICD-10 Finland
Other specified disorders involving the immune mechanism, not elsewhere classified
18.0
6.3
9
5
GD1FN
NOMESCO Finland
Lung ventilation isotope imaging
18.0
6.3
9
5
J15.6
ICD-10 Finland
Pneumonia due to other Gram-negative bacteria
+∞
6.2
6
*
J16.0
ICD-10 Finland
Chlamydial pneumonia
+∞
6.2
6
*
J99.1*M33.9
ICD-10 Finland
Respiratory disorders in dermatopolymyositis
+∞
6.2
6
*
6BB16
NOMESCO Finland
NA
+∞
6.2
6
*
J14
ICD-10 Finland
Pneumonia due to Haemophilus influenzae
+∞
6.2
6
*
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.9
6.2
86
460
RF120
NOMESCO Finland
NA
3.1
6.2
31
100
L50.0
ICD-10 Finland
Allergic urticaria
2.3
6.2
52
227
ZYC01
NOMESCO Finland
Remote contact by phone
1.8
6.2
94
520
R01AD11
ATC
triamcinolone; nasal
1.5
6.2
174
1145
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
26.7
6.2
8
*
C10AA05
ATC
atorvastatin; oral
1.2
6.2
1155
10135
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
3.0
6.2
32
106
C34.36
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma
7.0
6.2
14
20
I47.2
ICD-10 Finland
Ventricular tachycardia
2.2
6.2
59
272
A05AA02
ATC
ursodeoxycholic acid; oral
2.9
6.2
36
127
GBB00
NOMESCO Finland
Tracheostomy
3.0
6.2
33
112
D07AD01
ATC
clobetasol; topical
1.4
6.2
360
2735
L95.9
ICD-10 Finland
Vasculitis limited to skin, unspecified
5.0
6.2
18
36
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
1.8
6.2
97
543
M01AE01
ATC
ibuprofen; systemic, rectal
1.2
6.2
2421
22828
M10
ICD-10 Finland
Gout
1.7
6.2
124
751
XFE00
NOMESCO Finland
Epicardial ultrasonography
2.0
6.2
77
397
N04BC05
ATC
pramipexole; oral
1.5
6.1
182
1212
UJF92
NOMESCO Finland
Capsular endoscopy
2.4
6.1
47
194
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.7
6.1
127
774
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
5.3
6.1
17
32
PAW37
NOMESCO Finland
Biopsy of temporal artery
3.3
6.1
28
85
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
5.7
6.1
16
28
M47.82
ICD-10 Finland
Other spondylosis, cervical region
1.8
6.1
95
531
L05
ICPC
Flank/axilla symptom/complaint
1.7
6.1
125
760
TK810
NOMESCO Finland
Hemofiltration
4.7
6.1
19
41
J01CF05
ATC
flucloxacillin; systemic
1.9
6.1
85
459
ZXD35
NOMESCO Finland
Usual procedure
1.9
6.1
79
416
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.8
6.1
98
553
K31.8
ICD-10 Finland
Other specified diseases of stomach and duodenum
3.9
6.1
23
60
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
2.7
6.1
38
143
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
1.8
6.0
100
571
K83.0
ICD-10 Finland
Cholangitis
2.5
6.0
44
179
ECB15
NOMESCO Finland
Plastic repair of oronasal or oroantral fistula
4.4
6.0
20
46
WX702
NOMESCO Finland
Supraglottic ventilation device
1.7
6.0
114
678
NDB78
NOMESCO Finland
Prosthetic replacement of several of finger or metacarpal
10.0
6.0
11
11
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
10.0
6.0
11
11
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
10.0
6.0
11
11
L16
ICPC
Ankle symptom/complaint
1.5
6.0
217
1510
N18.0
ICD-10 Finland
End-stage renal disease
2.8
6.0
35
124
E03.89
ICD-10 Finland
Other specified hypothyroidism
2.0
6.0
74
381
C08DB01
ATC
diltiazem; oral
1.5
6.0
173
1147
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3006184) Hemoglobin [Mass/volume] in Capillary blood
451
604
8.35
323.01
2.6
2.0
g/l
127.9
129.3
0.32
204
430
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
403
472
9.44
321.64
1.4
1.2
titre
202.1
57.1
—
19
7
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
275
179
16.50
319.98
2.1
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
236
75
33.51
307.65
2.2
1.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
2769
13303
5.11
307.65
13.4
4.9
e9/l
0.7
0.6
39.55
2559
11213
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
265
117
24.29
307.65
2.2
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
585
191
36.09
307.65
2.1
1.2
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1214
3290
4.97
307.65
9.9
6.3
kpa
5.0
5.0
0.19
1166
3148
(3027801) Oxygen [Partial pressure] in Arterial blood
1212
3289
4.96
307.65
9.9
6.3
kpa
10.0
12.8
79.89
1164
3140
(3037522) Nuclear Ab [Titer] in Serum
1347
3007
6.42
307.65
1.6
1.3
titre
590.0
467.6
1.47
381
628
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
326
179
19.85
307.65
3.5
3.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
480
362
15.05
307.65
12.3
4.9
iu/ml
1735.2
565.8
0.44
114
49
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
629
789
9.37
307.65
2.0
1.5
titre
308.9
241.0
0.25
46
41
(42870588) Differential panel, method unspecified - Blood
2285
9157
4.81
307.65
13.0
5.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
722
1281
6.74
307.65
2.3
1.7
g/l
1.1
1.5
4.37
671
1141
(3006315) Basophils [#/volume] in Blood
2772
13389
5.08
307.65
13.4
4.9
e9/l
0.0
0.0
1.82
2567
11294
(3013650) Neutrophils [#/volume] in Blood by Automated count
2827
15827
4.17
307.65
17.9
7.6
e9/l
5.0
4.1
60.13
2651
13573
(3023368) Bacteria identified in Blood by Culture
2193
7269
5.84
307.65
6.7
3.5
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
331
289
12.46
307.65
5.5
2.5
u/ml
748.0
1551.1
0.50
31
21
(44806118)
377
154
27.10
307.65
2.7
1.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
483
669
8.14
307.65
1.9
1.3
iu/ml
13.3
17.8
0.37
27
12
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
255
86
31.74
307.65
2.2
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
607
90
80.24
307.65
2.3
1.4
—
—
—
0
0
(44790047)
377
154
27.10
307.65
2.7
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
280
35
86.36
307.65
2.0
1.0
—
—
—
0
0
(44790048)
377
154
27.10
307.65
2.7
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
450
157
32.42
307.65
2.7
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
386
275
15.53
307.65
1.2
1.1
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
235
75
33.36
307.65
2.2
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
271
160
18.18
307.65
2.2
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
587
960
7.06
307.65
2.6
1.7
ug/l
2.4
3.0
0.26
533
809
(3005719) IgG [Mass/volume] in Serum or Plasma
920
1628
7.16
307.65
4.5
2.3
g/l
10.1
10.9
4.06
880
1465
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
487
174
32.01
307.65
1.9
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
376
370
11.18
307.65
1.7
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
948
1851
6.51
307.65
5.3
4.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
2806
13825
5.06
307.65
14.3
5.1
e9/l
0.2
0.2
0.21
2620
11821
(3003396) Base excess in Arterial blood by calculation
1200
3296
4.88
307.65
10.0
6.3
mmol/l
1.6
0.7
9.33
1010
2494
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
737
477
18.97
307.65
2.1
1.4
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
2662
12785
4.71
307.65
14.5
5.3
%
23.5
27.3
52.60
2600
11739
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
509
183
32.01
307.65
2.4
1.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
2654
12449
4.85
307.65
14.3
5.1
%
2.6
3.0
16.08
2594
11477
(3000494) Fungus identified in Specimen by Culture
1029
2910
4.49
307.65
2.5
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1371
2687
7.46
307.65
2.8
1.5
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
852
1034
10.36
307.65
1.8
1.4
u/ml
19.4
16.3
0.12
24
24
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1364
2706
7.34
307.65
2.7
1.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
2659
12512
4.84
307.65
14.7
5.4
%
8.9
9.0
0.89
2597
11584
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
690
238
35.28
307.65
2.1
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
586
257
26.83
307.65
2.5
1.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
946
762
16.25
307.65
3.3
2.3
—
—
—
0
0
(44790049)
377
154
27.10
307.65
2.7
1.3
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
2633
12618
4.63
307.65
13.8
5.1
%
61.7
57.5
54.89
2570
11660
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
747
356
25.94
307.65
2.4
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
733
345
26.15
307.65
2.5
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
400
320
13.87
307.65
3.4
2.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
2638
12084
4.97
307.65
14.1
5.2
%
0.6
0.7
17.84
2584
11161
(3023419) Bacteria identified in Sputum by Culture
494
195
29.02
307.65
3.0
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1702
3998
6.95
307.65
3.0
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
2777
13655
4.96
307.65
13.6
5.0
e9/l
1.9
1.9
0.25
2587
11702
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
514
212
27.93
307.65
1.9
1.2
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
1014
3025
4.22
302.83
10.9
6.5
%
93.5
96.0
22.15
977
2918
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
201
71
29.85
302.10
1.4
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
227
111
21.70
302.06
1.2
1.0
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
503
829
6.85
298.18
1.3
1.2
u/ml
1.9
0.6
0.99
52
75
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
314
300
11.33
290.09
1.6
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
314
300
11.33
290.09
1.6
1.1
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
580
1145
5.81
285.63
1.7
1.2
u/ml
235.0
204.7
0.34
538
1052
(3042936) Bacteria identified in Isolate by Culture
1140
3839
3.83
284.70
2.7
1.9
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
654
1468
5.18
278.54
11.4
8.4
mmol/l
24.8
23.9
7.00
611
1366
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
415
601
7.64
276.77
1.9
1.4
g/l
0.2
0.2
0.95
395
565
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
163
40
42.55
271.53
1.4
1.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
416
627
7.34
267.41
1.9
1.4
g/l
1.2
1.2
0.98
399
590
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
375
513
8.01
262.60
1.2
1.1
u/ml
33.3
11.0
—
9
5
(3017181) Myelocytes/100 leukocytes in Blood
798
2204
4.33
261.36
6.4
3.6
%
0.9
0.9
0.28
327
563
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1140
4045
3.61
260.28
1.4
1.2
iu/ml
56.9
35.3
3.45
410
1197
(3000492) Spirometry study
763
2043
4.43
260.27
3.0
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
885
2648
4.06
259.68
1.6
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
421
707
6.58
243.71
2.0
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
185
93
20.87
242.87
4.4
3.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
734
2008
4.30
242.26
6.2
3.5
%
0.5
0.5
0.12
261
406
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
126
15
86.88
239.03
3.0
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
355
515
7.51
235.61
5.9
3.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2399
13718
3.07
234.33
11.0
5.3
mmol/l
1.2
1.2
13.02
2264
12248
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2538
14987
3.13
233.66
10.8
5.6
umol/l
11.2
12.8
6.67
2457
14162
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1052
3777
3.48
232.73
1.3
1.2
u/ml
34.3
13.8
2.06
329
1386
(4010399)
680
1816
4.35
231.09
2.1
1.4
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
209
154
14.31
226.52
2.4
2.3
e9/l
1.0
1.0
0.47
152
83
(3018418) pH of Serum or Plasma
1780
8804
2.94
224.49
6.2
3.5
ph
7.4
7.4
1.24
441
1595
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
624
1597
4.49
223.81
6.9
3.2
mmol/l
2.5
1.4
9.43
513
1118
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
198
136
15.31
223.15
1.7
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
198
136
15.31
223.15
1.7
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
198
136
15.31
223.15
1.7
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
637
1660
4.42
223.14
7.0
3.3
ph
7.4
7.4
3.19
120
184
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
641
1686
4.38
221.75
7.1
3.3
kpa
5.2
5.1
1.21
609
1523
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1134
4414
3.25
218.10
7.3
2.8
mmol/l
0.8
0.8
2.08
1058
4085
(3024980) IgG subclass 4 [Mass/volume] in Serum
263
292
9.61
217.36
1.7
1.7
g/l
0.9
0.9
0.20
192
230
(3028192) IgG subclass 2 [Mass/volume] in Serum
207
161
13.55
217.32
1.4
1.4
g/l
2.8
3.1
1.03
144
114
(3027135) IgG subclass 1 [Mass/volume] in Serum
207
161
13.55
217.32
1.4
1.4
g/l
7.6
6.8
0.79
143
111
(3024139) IgG subclass 3 [Mass/volume] in Serum
207
161
13.55
217.32
1.4
1.4
g/l
0.5
0.5
0.10
143
115
(3021440) Promyelocytes/100 leukocytes in Blood
725
2118
4.00
217.15
6.6
3.7
%
0.1
0.1
0.82
306
524
(4062490)
206
163
13.31
214.03
1.4
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1876
9742
2.85
212.73
4.6
2.8
ng/l
2106.5
1546.0
3.99
1703
8414
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
611
1600
4.37
212.13
12.4
6.8
mmol/l
25.2
24.5
3.53
601
1588
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2505
15201
2.94
209.41
12.1
5.9
mmol/l
1.2
1.2
5.22
2104
12748
(1175426) CD3 cells/100 lymphocytes in Blood
178
113
16.49
209.05
2.3
2.4
%
71.2
69.2
0.49
171
104
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
465
995
5.19
206.93
1.8
1.8
u/l
37.7
38.6
0.34
419
843
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
175
110
16.64
206.55
2.2
2.4
%
16.5
18.0
0.28
66
46
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1272
5446
3.02
205.48
2.7
1.6
mg/l
1.7
1.4
1.25
1065
4188
(3025159) Blasts/100 leukocytes in Blood
685
2005
3.95
203.80
6.5
3.7
%
0.3
0.4
0.10
272
447
(3002173) Hemoglobin [Mass/volume] in Arterial blood
830
2794
3.53
200.28
12.4
6.9
g/l
122.3
120.8
1.18
805
2697
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
640
1816
4.04
198.62
2.0
1.5
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
168
107
16.39
196.89
2.4
2.4
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
345
586
6.38
196.55
1.4
1.2
u/ml
12.4
3.9
0.73
48
51
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
317
494
6.92
196.34
1.3
1.2
u/ml
6.4
6.6
0.01
30
35
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
346
594
6.31
194.99
1.4
1.2
u/ml
12.1
7.0
0.64
75
93
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
353
629
6.09
191.47
1.4
1.2
u/ml
33.1
46.2
0.31
17
37
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
295
437
7.24
191.45
5.2
3.3
%
60.4
57.6
2.27
295
437
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
142
69
21.35
188.83
2.2
1.8
u/ml
64702.0
78834.3
—
21
6
(3020779) Urea [Moles/volume] in Serum or Plasma
778
2619
3.48
186.67
12.5
6.3
mmol/l
11.1
10.5
1.23
742
2473
(3015235) Bicarbonate [Moles/volume] in Capillary blood
352
645
5.92
185.33
5.4
2.6
mmol/l
25.5
24.5
3.20
323
551
(3027315) Oxygen [Partial pressure] in Blood
322
542
6.40
184.90
7.9
3.3
kpa
8.0
8.6
5.94
313
529
(3012501) Base excess in Blood by calculation
319
540
6.36
182.10
7.9
3.3
mmol/l
3.0
2.5
1.42
247
331
(3013290) Carbon dioxide [Partial pressure] in Blood
319
540
6.36
182.10
7.9
3.3
kpa
5.0
4.9
1.68
310
527
(3028626) Oxygen [Partial pressure] in Capillary blood
329
576
6.16
181.52
6.4
3.2
kpa
7.6
8.2
6.28
313
529
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
328
575
6.15
180.71
1.8
1.9
mg/l
11.4
11.2
0.14
303
520
(21494815) CD4 cells/100 lymphocytes in Specimen
165
120
14.34
179.86
2.3
2.4
%
29.9
45.9
—
9
21
(3010421) pH of Blood
344
641
5.81
177.79
7.7
3.3
ph
7.4
7.4
0.61
310
528
(3036481) Cortisol [Moles/volume] in Serum or Plasma
664
2091
3.64
175.88
2.2
2.2
nmol/l
342.8
385.7
3.76
620
1902
(3021901) Oxygen saturation in Capillary blood
289
459
6.74
175.48
5.1
2.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1206
5402
2.81
174.64
9.9
4.0
—
—
—
0
0
(3026782) Osmolality of Urine
1265
5839
2.76
172.48
4.3
2.7
mosm/kgh2o
527.8
561.1
7.51
1149
4902
(40767503) Oxygen content in Capillary blood by calculation
311
545
6.13
171.24
3.8
2.1
%
15.7
16.2
0.83
173
271
(3000850) Epithelial cells [#/volume] in Urine
1323
6291
2.70
169.59
4.2
2.5
e6/l
4.7
4.4
0.33
1219
5458
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
261
387
7.17
168.95
1.4
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1697
9166
2.55
166.43
5.5
3.2
e6/l
108.6
100.7
0.04
1425
6998
(3007164) IgA [Mass/volume] in Serum or Plasma
1028
4326
2.89
166.40
2.0
1.4
g/l
2.8
2.6
1.83
766
2428
(3021589) Normoblasts [#/volume] in Blood
2062
12214
2.52
165.48
21.9
8.8
e9/l
0.0
0.0
0.33
1796
9929
(40757373) Influenza virus identified in Isolate
99
24
42.34
164.89
2.8
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
1551
8065
2.57
164.39
5.2
3.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
529
1501
3.94
162.56
1.8
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
694
2372
3.36
160.77
12.4
7.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
239
346
7.31
157.99
1.4
1.4
u/ml
140.1
114.2
0.46
48
72
(40758558) Short blood count panel - Blood
1369
6815
2.59
157.63
12.5
5.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
111
46
24.83
157.08
2.9
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
904
3671
2.93
155.05
8.5
5.2
mmol/l
1.1
1.0
1.91
839
3397
(3010375) cycloSPORINE [Mass/volume] in Blood
121
65
19.20
153.80
44.7
21.9
ug/l
153.8
123.3
2.25
99
55
(3014111) Lactate [Moles/volume] in Serum or Plasma
706
2502
3.24
153.61
11.4
6.2
mmol/l
1.5
1.4
1.39
675
2408
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1559
8332
2.49
153.30
5.7
3.0
u/l
34.5
35.9
0.28
1501
7858
(3030467) Casts [#/volume] in Urine by Automated count
1564
8382
2.48
152.73
5.3
3.1
e6/l
0.4
0.4
0.92
1289
6293
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
854
3390
2.97
152.42
4.8
3.7
u/l
273.0
245.7
4.05
811
3166
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
313
619
5.42
151.15
1.6
1.6
iu/ml
11.8
13.8
0.05
73
129
(3024561) Albumin [Mass/volume] in Serum or Plasma
2124
13128
2.42
149.76
7.3
4.4
g/l
32.8
35.3
65.26
1993
12104
(3008152) Bicarbonate [Moles/volume] in Arterial blood
584
1872
3.51
149.11
9.8
5.9
mmol/l
25.2
24.2
7.48
557
1744
(3018095) Leukocytes [#/volume] in Urine
1814
10482
2.41
148.70
6.6
3.6
e6/l
87.7
101.8
0.21
1463
7497
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
126
79
16.47
148.61
3.6
1.7
ug/l
44.8
72.0
1.31
126
74
(3024891) Influenza virus A+B Ag [Presence] in Specimen
235
357
6.95
148.51
1.4
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
631
2141
3.34
147.06
1.6
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2935
21138
2.77
146.91
10.6
3.8
mm/h
19.6
12.6
77.92
2857
19283
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
319
667
5.13
144.50
3.4
2.6
g/l
3.9
3.4
6.06
309
632
(3002032) Base excess in Venous blood by calculation
733
2750
3.07
143.97
5.1
3.3
mmol/l
2.4
1.8
4.34
609
2182
(3032080) INR in Blood by Coagulation assay
2088
12962
2.37
143.53
13.9
9.5
inr
1.3
1.3
1.01
721
3425
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
334
732
4.91
143.12
1.8
1.6
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
104
47
22.73
142.25
2.2
2.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
2569
17526
2.47
141.43
10.0
4.1
mmol/l
6.9
6.8
1.49
2481
16398
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
944
4109
2.73
140.35
3.1
2.4
%
20.0
22.9
8.33
798
3465
(3021447) Carbon dioxide [Partial pressure] in Venous blood
727
2760
3.03
139.49
5.0
3.3
kpa
6.0
5.8
3.34
695
2677
(3012544) pH of Venous blood
745
2870
2.99
139.24
5.0
3.3
ph
7.4
7.4
—
7
20
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
729
2791
3.00
137.65
4.8
2.6
ng/l
252.4
209.9
1.69
683
2558
(3004789) Transferrin [Mass/volume] in Serum or Plasma
977
4379
2.66
136.58
3.0
2.4
g/l
2.2
2.3
3.37
906
4029
(3042733) HLA Ab [Presence] in Serum
102
50
20.94
134.88
4.3
4.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
654
2390
3.10
133.76
1.6
1.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
1024
4744
2.59
133.38
3.0
2.4
umol/l
10.9
13.0
19.42
963
4363
(3021879) Hepatitis B virus core Ab [Presence] in Serum
461
1364
3.71
132.20
1.4
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
105
59
18.28
130.59
2.2
2.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
874
3810
2.69
128.27
12.7
6.1
mmol/l
103.7
104.6
5.93
848
3741
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
118
87
13.97
127.38
1.8
1.4
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
118
87
13.97
127.38
1.8
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
118
87
13.97
127.38
1.8
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
116
87
13.73
123.97
1.8
1.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
118
93
13.07
122.46
1.5
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
421
1234
3.72
122.07
7.5
3.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3000
22641
2.61
122.02
16.1
6.7
u/l
79.4
80.4
0.53
2932
21109
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
520
1749
3.29
121.68
2.1
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1153
5897
2.38
119.06
5.9
3.5
ng/l
421.3
596.2
0.49
1034
5001
(3039162) Centromere protein B Ab [Units/volume] in Serum
184
273
7.04
118.62
1.3
1.2
u/ml
60.9
38.0
0.53
20
16
(3013637) Mi-2 Ab [Presence] in Serum
101
64
16.19
118.34
1.1
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
101
64
16.19
118.34
1.1
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
101
64
16.19
118.34
1.1
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
101
64
16.19
118.34
1.1
1.0
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
125
115
11.21
117.57
2.4
2.0
e6/l
487.9
424.5
0.61
103
96
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
367
1005
3.94
117.25
4.0
2.9
u/ml
0.3
0.4
1.80
218
560
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
103
69
15.32
117.21
1.8
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
103
69
15.32
117.21
1.8
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
103
69
15.32
117.21
1.8
1.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
489
1622
3.32
116.84
15.7
8.7
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
229
430
5.61
116.62
1.4
1.2
u/ml
62.6
43.5
0.75
38
40
(3020630) Protein [Mass/volume] in Serum or Plasma
651
2563
2.86
115.27
2.3
2.2
g/l
65.7
66.7
2.22
601
2288
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
113
93
12.50
114.17
1.7
1.2
u/ml
1.8
1.7
0.04
76
31
(3028433) Virus identified in Specimen by Culture
98
64
15.70
113.01
1.2
1.1
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
193
323
6.24
110.75
1.2
1.2
u/ml
357.5
264.4
1.89
125
195
(3048929) Epstein Barr virus Ab [Presence] in Serum
228
449
5.34
110.12
1.2
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
92
56
16.82
109.97
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
91
56
16.63
108.17
1.1
1.1
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
115
106
11.16
107.98
2.5
2.1
e9/l
0.2
0.2
0.37
101
93
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
199
353
5.90
107.57
1.2
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
283
688
4.37
105.98
3.6
2.4
%
90.6
86.9
1.78
271
647
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
423
1360
3.38
105.87
4.8
3.7
mmol/l
24.6
23.9
3.32
384
1201
(3008536) Aspergillus sp Ab [Presence] in Serum
70
24
29.70
105.53
1.7
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
569
2184
2.89
104.98
2.1
2.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
147
196
7.76
104.16
1.4
1.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1286
7277
2.17
100.92
7.0
3.7
%
84.8
85.4
0.36
1260
7119
(3031040) Bacteria [#/volume] in Urine by Automated count
2610
19243
2.17
100.36
7.2
4.5
e6/l
696.1
2488.3
1.84
46
283
(3027945) Reticulocytes/100 erythrocytes in Blood
800
3737
2.45
98.87
3.8
2.2
%
1.9
1.7
6.20
712
3248
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1798
11609
2.05
98.54
5.9
3.5
ng/l
132.7
94.3
0.16
1473
8691
(3026250) Tacrolimus [Mass/volume] in Blood
93
71
13.41
98.26
41.1
35.4
ug/l
8.0
7.4
1.34
85
65
(3037467) Urinalysis macro (dipstick) panel - Urine
2669
19990
2.16
96.44
7.6
4.2
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
144
207
7.19
95.43
2.1
1.2
iu/ml
20.0
28.4
—
9
8
(3018677) aPTT in Platelet poor plasma by Coagulation assay
932
4747
2.28
93.88
3.1
1.9
s
29.9
30.1
0.37
908
4600
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
256
636
4.25
92.99
3.8
2.6
%
219.7
198.0
2.78
244
600
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
126
162
8.01
92.03
1.3
1.1
titre
159.6
185.0
0.12
23
26
(3004616) Nuclear Ab [Presence] in Serum
170
307
5.75
90.07
1.3
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
169
305
5.75
89.59
1.4
1.2
u/ml
5.3
3.9
0.16
69
94
(3007853) Bacteria identified in Skin by Aerobe culture
675
3043
2.48
89.33
2.3
1.6
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
97
92
10.80
89.27
2.4
2.7
%
38.7
36.1
0.34
46
35
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1755
11514
1.98
89.04
3.0
2.1
nmol/l
78.0
79.4
1.15
1613
10072
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
623
2717
2.55
88.41
2.3
2.1
g/l
0.2
0.2
0.19
580
2523
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
487
1891
2.81
87.06
15.4
7.8
%
0.6
0.7
0.36
480
1877
(3024354) Oxygen [Partial pressure] in Venous blood
555
2306
2.65
86.92
4.1
2.8
kpa
4.4
4.4
0.12
529
2230
(4015189)
73
46
16.16
85.64
2.4
1.7
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
485
1901
2.78
85.07
15.4
7.6
%
1.4
1.3
2.40
478
1890
(3009871) Measles virus Ab [Titer] in Serum
73
48
15.49
83.76
1.4
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
126
182
7.13
83.09
2.2
2.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
159
292
5.64
82.71
1.3
1.2
u/ml
2.9
4.4
0.80
93
130
(4306422)
157
287
5.67
82.07
1.3
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
123
176
7.19
81.80
1.1
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1297
7846
2.00
81.27
2.8
2.2
mg/l
3.3
3.0
2.87
1146
6616
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
129
196
6.78
81.17
1.2
1.1
u/ml
33.7
2.2
—
9
11
(3036489) Thrombin time
300
915
3.48
81.01
3.5
2.0
s
21.5
21.8
0.36
275
825
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
49
12
41.36
80.97
1.3
1.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1287
7776
2.00
80.83
5.5
2.6
umol/l
2120.7
6502.6
5.35
1142
6603
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1468
9286
1.95
80.62
3.8
2.0
u/l
165.0
207.3
1.25
1392
8673
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
153
279
5.67
80.18
1.3
1.1
%
118.2
113.9
0.66
146
252
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
913
4877
2.15
80.06
4.5
3.0
e6/l
1.8
1.9
0.21
530
2715
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
100
115
8.91
79.91
2.5
1.9
e6/l
689.9
625.8
0.31
44
56
(3014148) Varicella zoster virus Ab [Titer] in Serum
123
184
6.88
78.52
1.1
1.1
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
131
210
6.43
78.29
1.3
1.1
u/ml
65.9
51.9
—
8
14
(3015377) Calcium [Moles/volume] in Serum or Plasma
1567
10219
1.91
77.79
4.6
3.1
mmol/l
2.3
2.4
7.28
1409
8738
(3006245) CD3-CD19+ cells/100 cells in Blood
72
53
13.83
77.62
2.3
2.2
%
9.4
9.1
0.06
65
44
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1934
13515
1.89
77.37
3.3
2.3
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
132
216
6.30
77.31
1.2
1.1
u/ml
34.6
86.7
—
7
8
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
358
1253
3.05
76.96
6.8
4.3
%
1.8
1.6
2.15
335
1182
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
72
54
13.57
76.78
2.3
2.2
%
30.8
29.0
0.31
67
48
(3004809) Band form neutrophils/100 leukocytes in Blood
183
412
4.62
75.24
4.4
3.3
%
1.6
1.3
0.69
159
299
(3017569) Oxygen content in Arterial blood
101
131
7.90
73.18
2.2
1.9
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
128
216
6.10
72.68
1.1
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
282
888
3.35
72.24
9.6
5.2
mmol/l
1.4
1.3
0.82
256
782
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
385
1459
2.83
71.49
1.9
1.6
g/l
1.7
1.5
2.85
324
1234
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
147
287
5.29
71.46
1.2
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
252
751
3.52
70.35
1.5
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
608
2887
2.32
70.30
3.7
2.3
e9/l
73.8
66.9
3.42
429
2184
(3026008) Bacteria identified in Urine by Culture
1400
9023
1.88
70.20
4.0
3.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
107
156
7.03
69.93
1.3
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
107
156
7.03
69.93
1.3
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
107
156
7.03
69.93
1.3
1.2
—
—
—
0
0
(4268621)
117
188
6.39
69.74
2.4
2.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1661
11322
1.84
69.38
3.6
2.7
ug/l
216.2
146.4
9.11
1536
10244
(3037756) Immunofixation for Serum or Plasma
223
619
3.77
69.20
1.4
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
259
797
3.42
68.77
4.7
3.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
107
159
6.90
68.71
1.3
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
107
159
6.90
68.71
1.3
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
107
159
6.90
68.71
1.3
1.2
—
—
—
0
0
(3019977) pH of Arterial blood
102
144
7.25
68.63
2.7
2.1
ph
7.4
7.4
0.34
60
51
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1364
8780
1.87
68.19
3.2
2.4
u/l
61.4
60.6
0.06
1277
8043
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
187
469
4.14
66.84
1.3
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
542
2504
2.36
66.53
5.7
3.4
mmol/l
1.2
1.2
4.57
509
2144
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
616
3006
2.25
66.47
3.1
2.7
umol/l
9.0
9.6
0.30
538
2637
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
629
3099
2.24
66.30
5.4
3.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
337
1237
2.89
66.25
7.3
4.4
%
0.8
0.9
1.03
314
1168
(3035350) Ketones [Presence] in Urine by Test strip
1932
13915
1.80
66.11
5.4
3.6
estimate
0.0
0.0
0.00
552
2490
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
279
933
3.15
64.60
3.8
2.2
ug/l
367.6
842.1
1.34
269
891
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
306
1082
2.99
64.31
9.0
3.6
mmol/l
25.3
24.5
4.76
292
966
(3020891) Body temperature
322
1189
2.87
62.52
6.5
4.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1919
13938
1.77
62.47
7.3
4.9
estimate
0.0
0.0
0.00
562
2484
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
180
464
4.02
61.96
1.1
1.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1938
14148
1.76
61.68
5.4
3.7
estimate
0.0
0.0
0.80
542
2422
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
187
504
3.85
60.47
2.0
1.6
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
904
5256
1.95
60.46
4.2
2.8
e6/l
0.8
1.1
2.26
527
3058
(3039000) Anion gap in Blood
216
652
3.45
59.00
9.5
6.0
mmol/l
11.8
11.3
0.86
197
586
(3018572) Chloride [Moles/volume] in Blood
216
653
3.45
58.86
9.5
6.0
mmol/l
103.8
105.4
5.22
197
587
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
88
126
7.13
58.45
1.1
1.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
297
1089
2.88
58.33
2.9
1.6
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
39
15
26.26
56.28
1.1
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
61
59
10.49
55.30
1.1
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
300
1146
2.76
54.47
2.4
1.9
g/l
10.7
10.3
0.58
256
946
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
312
1218
2.70
54.30
2.3
1.8
g/l
3.9
3.8
0.52
236
855
(3018405) Lactate [Moles/volume] in Arterial blood
281
1039
2.84
54.26
5.2
3.5
mmol/l
1.4
1.4
0.01
276
1028
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
312
1220
2.70
54.12
2.3
1.8
g/l
8.0
7.3
5.92
241
890
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
312
1220
2.70
54.12
2.3
1.8
—
—
—
0
0
(3015736) pH of Urine
1536
10771
1.72
54.07
4.4
3.4
—
5.7
—
0
15
(4035726)
523
2597
2.18
53.26
1.4
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
271
993
2.86
53.20
2.6
2.6
mg/l
60.6
110.9
0.43
193
817
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
270
988
2.87
53.13
2.6
2.6
mg/l
50.9
49.2
0.07
191
812
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
264
965
2.87
52.04
2.6
2.6
ratio
3.4
2.9
0.12
17
75
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
293
1139
2.71
51.36
2.4
1.9
g/l
3.3
3.0
4.97
239
878
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
113
235
4.93
51.07
1.1
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
480
2340
2.21
51.07
6.0
3.8
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
116
247
4.81
50.98
1.5
1.3
mmol/l
6.7
6.2
0.67
105
230
(3027273) Bicarbonate [Moles/volume] in Venous blood
347
1482
2.48
50.10
5.1
2.9
mmol/l
25.7
25.0
2.66
324
1434
(3004119) Hemoglobin [Mass/volume] in Venous blood
406
1869
2.31
49.52
5.3
3.0
g/l
125.0
128.6
2.56
390
1820
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
248
901
2.88
49.40
2.3
1.9
g/l
0.1
0.0
0.55
230
812
(3008757) Leukocyte morphology finding [Identifier] in Blood
119
269
4.54
48.62
5.0
3.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
110
234
4.81
48.40
1.2
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
268
1036
2.71
47.43
2.4
2.0
g/l
0.7
1.0
0.77
237
871
(3021788) Differential panel - Synovial fluid
167
492
3.51
47.30
1.7
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
232
842
2.87
46.27
2.4
1.9
g/l
0.0
0.0
0.50
214
757
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
252
960
2.74
45.86
2.3
1.8
g/l
35.6
38.0
6.79
227
794
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
228
824
2.88
45.82
2.4
1.9
g/l
0.0
0.0
0.00
214
754
(40760888) Immunoglobulin light chains.free panel - Serum
209
721
3.01
45.66
2.5
2.8
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
80
135
6.03
45.41
2.2
1.5
u/l
6.2
6.7
0.22
72
119
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
94
187
5.13
44.73
1.3
1.3
u/l
15.7
12.2
0.66
84
177
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
124
312
4.08
44.08
8.7
6.4
mg/l
11.8
12.2
0.38
115
298
(3051651) Icteric interference index of Serum or Plasma
78
134
5.92
43.48
6.3
3.1
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
294
1250
2.47
42.70
1.4
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
50
53
9.55
42.44
1.1
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
51
56
9.22
42.17
1.1
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
256
1025
2.61
42.16
2.5
1.6
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
137
383
3.67
41.98
1.6
1.4
g/l
32.3
31.8
0.18
118
348
(3000060) B lymphocytes [#/volume] in Blood
42
35
12.12
41.93
2.5
2.1
e6/l
1102.9
177.5
0.43
21
12
(3023183) Ammonium ion [Moles/volume] in Plasma
167
538
3.20
41.00
2.5
2.6
umol/l
32.6
34.4
0.45
144
444
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
107
257
4.26
40.47
1.4
1.3
u/l
507.5
329.7
1.49
98
247
(3013293) Extractable nuclear Ab [Presence] in Serum
37
27
13.83
39.93
1.5
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
979
6495
1.69
39.60
1.9
1.8
nmol/l
1186.5
1152.3
0.48
743
4817
(3002385) Erythrocyte distribution width [Ratio]
2694
22836
1.63
38.56
44.7
16.8
%
14.5
13.8
95.93
2669
22256
(3045788) Cell count panel - Pleural fluid
102
252
4.13
37.18
1.6
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
164
555
3.04
37.03
1.3
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
68
121
5.70
36.57
1.2
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1054
7253
1.63
36.43
5.6
3.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
463
2519
1.96
35.99
3.0
2.3
u/l
36.6
58.7
0.61
426
2156
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3173
28287
1.78
35.30
42.2
12.9
mg/l
28.2
24.6
9.97
3047
22174
(3029937) Albumin [Presence] in Urine by Test strip
1086
7582
1.61
35.14
6.0
4.0
estimate
0.0
0.0
0.75
515
2372
(3012441) Differential panel - Pleural fluid
110
300
3.75
34.96
1.7
1.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
886
5912
1.65
34.29
3.1
2.9
mmol/l
2.5
2.5
9.77
787
5174
(3044242) Glucose [Moles/volume] in Arterial blood
70
137
5.19
33.96
1.8
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
201
795
2.61
33.87
1.6
1.3
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
115
331
3.55
33.76
1.7
1.3
e6/l
5747.8
1689.6
0.68
80
240
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
112
321
3.57
33.09
1.1
1.1
g/l
1.6
1.5
0.61
98
289
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
45
59
7.71
32.29
2.6
2.0
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
217
912
2.46
32.20
6.1
3.7
mmol/l
4.0
3.9
0.73
195
863
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
188
741
2.62
31.90
1.7
1.5
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
60
108
5.63
31.89
1.2
1.1
ratio
1.0
1.1
0.05
23
36
(3035880) pH of Pleural fluid
68
139
4.96
31.41
1.3
1.3
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
65
128
5.15
31.33
2.3
2.0
mmol/l
8.3
10.0
2.47
55
102
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
178
690
2.66
31.23
3.8
3.0
mg/l
1.8
1.6
2.03
165
622
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
410
2244
1.93
31.11
4.5
3.6
ng/l
112.3
91.1
2.44
356
1896
(3046861) Legionella sp Ag [Presence] in Urine
36
6
60.55
31.08
1.1
1.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2081
17059
1.49
30.80
4.7
3.0
u/l
68.8
52.2
6.45
1939
15519
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
28
20
14.10
30.50
1.4
1.2
ng/l
86.8
27.1
1.96
19
11
(3028308) Erythrocytes [#/volume] in Pleural fluid
104
300
3.54
30.45
1.6
1.3
e6/l
106408.4
100518.5
0.04
60
173
(40768806) Pleura Pathology biopsy report
105
305
3.51
30.42
1.6
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
113
347
3.33
30.02
1.1
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
119
378
3.22
29.93
1.1
1.3
miu/ml
195.6
209.8
0.12
19
142
(40768797) Stomach Pathology biopsy report
615
3853
1.71
29.77
1.3
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
66
138
4.85
29.70
1.3
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
170
663
2.64
29.47
3.0
3.0
nmol/l
0.9
0.8
0.41
136
497
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
58
109
5.39
29.45
4.1
3.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
955
6706
1.57
29.19
4.5
3.7
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
34
38
9.02
27.71
1.6
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
169
687
2.53
26.91
1.8
1.6
e6/l
15656.3
13106.3
0.21
123
496
(3011436) Histone Ab [Units/volume] in Serum
38
51
7.52
26.73
1.1
1.1
u/ml
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
161
644
2.57
26.52
1.2
1.2
titre
675.0
969.5
—
6
21
(3040151) Glucose [Moles/volume] in Capillary blood
103
327
3.21
25.96
16.1
5.6
mmol/l
7.5
7.3
0.24
92
262
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
475
2876
1.75
25.75
2.8
2.3
ug/l
10.4
7.4
2.19
412
2475
(3016650) Hepatitis A virus Ab [Presence] in Serum
101
320
3.22
25.54
1.1
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
150
592
2.60
25.40
4.1
3.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
109
363
3.06
25.35
1.2
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
166
689
2.47
25.30
2.0
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
747
5121
1.57
24.81
1.3
1.2
u/ml
1.1
1.8
2.95
192
1287
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
20
11
18.27
24.72
1.1
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
20
11
18.27
24.72
1.2
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
134
507
2.70
24.68
1.7
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
420
2485
1.78
24.61
1.7
1.7
%
1.7
1.5
3.04
361
2147
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1372
10679
1.45
24.55
5.8
3.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
122
441
2.83
24.51
1.8
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
157
646
2.49
24.38
1.3
1.2
titre
129.4
86.5
0.56
17
37
(3045142) Bone marrow Pathology biopsy report
99
320
3.15
24.23
1.4
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
42
71
5.97
23.85
1.4
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
2423
20966
1.44
23.81
6.3
4.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
92
291
3.22
23.35
6.1
3.0
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
668
4521
1.58
23.30
29.3
27.2
inr
1.5
1.5
0.42
71
648
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
452
2778
1.71
23.09
1.5
1.3
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
112
403
2.83
22.72
1.1
1.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
86
266
3.29
22.65
1.9
1.5
%
37.9
27.5
1.59
50
174
(3048689) Calprotectin [Mass/mass] in Stool
430
2643
1.71
21.91
2.5
2.1
ug/g
216.2
153.3
1.89
361
2049
(3000570) Elastase.pancreatic [Mass/mass] in Stool
182
838
2.23
21.91
1.4
1.5
ug/g
271.4
266.1
0.13
106
526
(3000093) Morphology [Interpretation] in Blood Narrative
88
282
3.17
21.88
1.2
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
314
1771
1.84
21.48
3.4
3.1
e9/l
4.7
4.1
3.61
248
1281
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
99
345
2.92
21.31
1.7
1.5
%
60.9
60.8
0.01
59
218
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
30
40
7.55
21.21
1.7
1.3
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
44
87
5.11
21.17
1.0
1.1
u/ml
17.0
8.4
—
5
9
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
121
472
2.62
21.02
3.2
2.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1662
13645
1.39
20.95
5.6
3.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
96
335
2.91
20.62
1.5
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
1036
7865
1.44
20.34
1.8
1.5
nmol/l
18.9
20.3
2.31
937
6647
(3017354) Segmented neutrophils/100 leukocytes in Blood
84
276
3.09
20.05
5.1
3.2
%
54.6
57.4
0.47
62
162
(3044640) Blood type and Crossmatch panel - Blood
1199
9391
1.41
19.61
3.6
2.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
80
259
3.13
19.59
1.1
1.2
u/l
56.7
68.6
0.84
67
167
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
20
17
11.82
19.58
1.1
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
128
535
2.44
19.27
1.6
1.3
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
28
39
7.23
19.07
1.3
1.6
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
35
62
5.69
18.97
1.0
1.1
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
41
84
4.92
18.96
1.4
1.3
mmol/l
3.3
3.6
0.24
35
74
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
28
40
7.05
18.65
1.7
1.7
mg/l
6.1
8.9
1.37
23
31
(3029075) Extractable nuclear Ab panel - Serum
36
68
5.34
18.23
1.1
1.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1425
11593
1.37
18.17
2.5
2.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
60
171
3.55
18.00
1.4
1.2
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
41
88
4.70
17.96
5.9
7.0
mmol/l
24.7
24.9
0.10
34
78
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
68
214
3.22
17.48
1.1
1.1
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
64
194
3.34
17.48
1.9
1.6
mg/l
4.9
4.0
0.60
59
185
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
910
6910
1.42
17.38
1.8
1.7
pmol/l
59618495.0
23580425.9
0.61
733
5581
(3034891) Synovial lining cells/100 cells in Synovial fluid
50
130
3.88
17.14
1.8
1.4
%
2.7
3.6
0.22
14
35
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
33
61
5.45
17.11
1.0
1.2
%
93.7
81.0
1.56
20
30
(3019832) Treponema pallidum Ab [Presence] in Serum
196
1021
1.97
17.06
1.4
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
54
149
3.66
17.01
1.5
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
54
149
3.66
17.01
1.5
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
58
168
3.49
17.00
1.6
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
111
461
2.45
16.98
1.3
1.3
mmol/l
66.5
61.7
0.59
100
364
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
33
62
5.36
16.82
1.0
1.5
%
95.0
78.8
1.78
21
32
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
58
170
3.45
16.70
1.6
1.3
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
19
19
10.05
16.70
1.5
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
19
19
10.05
16.70
1.5
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
19
19
10.05
16.70
1.5
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
72
242
3.01
16.59
1.3
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
38
82
4.67
16.56
1.1
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
92
355
2.63
16.40
1.7
1.8
ug/l
26.9
25.8
0.05
87
346
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
41
95
4.35
16.37
1.1
1.1
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
46
118
3.93
16.08
1.7
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
46
118
3.93
16.08
1.7
1.3
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
27
44
6.17
15.92
1.1
1.2
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
19
5
38.21
15.37
1.0
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
73
259
2.85
15.30
2.6
3.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
90
357
2.56
15.20
1.1
1.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
61
197
3.13
15.07
1.4
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
83
319
2.64
14.95
1.7
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
83
320
2.63
14.86
1.7
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
83
320
2.63
14.86
1.7
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
83
321
2.62
14.77
1.7
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
928
7238
1.37
14.75
3.3
2.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
83
323
2.61
14.59
1.7
1.3
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
46
127
3.65
14.52
7.1
5.1
mg/l
61.4
72.9
0.60
34
92
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
83
326
2.58
14.32
1.7
1.3
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1573
13321
1.31
14.16
2.3
2.0
pmol/l
91.7
94.2
1.39
854
6930
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
31
65
4.80
14.00
1.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
27
51
5.33
13.70
4.8
2.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
20
28
7.18
13.54
1.5
1.0
—
—
—
0
0
(44806071)
16
17
9.45
13.44
1.0
1.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2342
21012
1.30
13.31
4.0
3.7
pmol/l
15.0
15.0
0.27
2103
18693
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
45
130
3.49
13.31
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
45
130
3.49
13.31
1.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
22
35
6.32
13.27
1.5
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
18
8
22.60
12.88
1.2
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
18
8
22.60
12.88
1.2
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
66
245
2.72
12.77
1.2
1.3
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
31
71
4.39
12.61
1.3
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
83
347
2.42
12.61
1.2
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
53
178
3.01
12.31
1.2
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
45
138
3.29
12.16
1.0
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
16
6
26.77
12.03
2.1
1.7
umol/l
44.3
38.7
—
16
6
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
17
23
7.42
11.84
1.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
50
167
3.02
11.74
1.4
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2693
24825
1.30
11.35
39.6
15.2
%
38.3
39.1
4.28
1720
15983
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
30
73
4.13
11.32
1.4
1.3
%
25.0
24.2
0.04
19
61
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
31
78
4.00
11.19
3.7
2.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
31
78
4.00
11.19
3.7
2.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
21
38
5.55
11.16
2.0
1.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
351
2425
1.49
10.71
4.0
2.6
ml/min/173m2
55.9
62.6
2.79
168
1010
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
54
200
2.72
10.56
1.3
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
137
748
1.86
10.46
1.3
1.1
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
12
12
10.03
10.44
1.4
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
264
1729
1.57
10.31
2.4
2.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
136
746
1.85
10.24
1.3
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1193
10053
1.27
10.21
3.7
3.1
mmol/l
7.0
7.4
2.44
984
8344
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
464
3414
1.41
10.13
3.1
4.0
ug/l
13.6
22.9
0.88
380
2846
(3025018) Bordetella pertussis Ab [Titer] in Serum
33
94
3.53
10.03
1.3
1.2
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
36
109
3.33
9.98
1.5
1.5
%
54.9
74.9
1.85
25
86
(3041918) Cholesterol [Moles/volume] in Pleural fluid
24
55
4.39
9.79
1.3
1.1
mmol/l
1.8
1.5
0.59
12
31
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
44
153
2.90
9.69
1.5
1.6
u/l
9.5
6.2
0.60
26
65
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
207
1299
1.63
9.68
2.8
3.1
pmol/l
4.2
4.4
2.68
176
1126
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
43
148
2.93
9.64
2.5
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
133
740
1.83
9.59
1.3
1.1
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
20
40
5.02
9.56
1.0
1.2
%
106.6
80.6
—
7
11
(40761511) CBC panel - Blood by Automated count
3097
29295
1.32
9.53
31.8
13.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
274
1844
1.52
9.48
1.2
1.2
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
16
26
6.18
9.45
1.6
1.2
ug/l
122.9
131.4
—
8
17
(3001893) Eosinophils/100 leukocytes in Pleural fluid
33
99
3.35
9.29
1.5
1.5
%
1.7
2.6
0.38
25
81
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
48
181
2.67
9.11
1.3
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
38
126
3.04
9.11
1.6
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
43
153
2.83
9.10
1.9
1.7
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
21
46
4.59
9.05
1.0
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
58
241
2.43
9.03
1.2
1.1
u/ml
1.9
1.9
0.00
30
80
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
28
77
3.66
8.98
1.2
1.3
ug/l
136.4
985.1
1.00
13
38
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
18
35
5.16
8.88
1.3
1.2
u/l
417.4
874.0
0.21
11
26
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
38
128
2.99
8.87
1.6
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
54
219
2.49
8.86
1.3
1.1
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
12
15
8.02
8.86
2.3
2.5
%
3.5
1.3
0.50
12
15
(40768443) Skin Pathology biopsy report
208
1339
1.59
8.78
1.2
1.2
—
—
—
0
0
(3036603) Volume of Urine
46
174
2.66
8.69
1.4
1.4
ml
1639.7
1710.9
0.14
14
42
(3019550) Sodium [Moles/volume] in Serum or Plasma
3166
30134
1.32
8.63
42.4
16.4
mmol/l
138.9
139.7
49.74
3121
29308
(3012516) Albumin [Mass/volume] in Urine
1155
9851
1.25
8.60
3.7
3.2
mg/l
677.1
281.0
1.68
793
6246
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
28
80
3.52
8.51
6.7
8.0
—
—
—
0
0
(3000012) Reticulocyte production index
48
188
2.57
8.48
2.1
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
53
219
2.44
8.38
1.3
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
19
41
4.65
8.34
1.0
1.2
%
79.8
78.3
—
6
11
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
30
91
3.32
8.33
3.1
3.0
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
27
77
3.52
8.23
6.6
1.5
umol/l
170.1
162.9
0.04
17
44
(3023103) Potassium [Moles/volume] in Serum or Plasma
3168
30198
1.31
8.22
42.8
16.6
mmol/l
4.0
4.0
1.59
3117
29325
(3022145) Colonoscopy Study observation
422
3164
1.38
8.19
1.3
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
117
661
1.79
8.08
1.3
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
45
177
2.56
7.90
1.1
1.1
u/ml
1.4
2.2
0.28
18
48
(21494890) Protein electrophoresis panel - 24 hour Urine
66
308
2.16
7.90
1.5
1.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1202
10390
1.23
7.73
4.5
3.9
mg/mmol
15.3
7.7
3.92
787
6555
(21494434) Karyotype in Bone marrow
59
266
2.24
7.69
1.3
1.2
—
—
—
0
0
(3013512) EKG study
1089
9329
1.24
7.60
5.5
4.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
50
212
2.38
7.51
1.1
1.0
u/ml
5.4
3.8
0.28
29
94
(44786800) Granulocytes/100 leukocytes in Body fluid
16
33
4.86
7.40
1.3
1.4
%
25.9
11.0
—
9
19
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
31
104
3.00
7.34
1.5
1.3
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
18
42
4.30
7.21
1.2
1.1
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
16
34
4.72
7.16
1.3
1.2
nmol/l
9.6
282149.7
0.49
11
28
(3035320) C reactive protein [Mass/volume] in Body fluid
45
187
2.42
7.08
3.2
2.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
163
1045
1.59
7.06
3.2
2.8
g/l
0.4
0.3
0.70
91
420
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2748
25924
1.22
6.77
5.1
4.5
mu/l
2.1
2.0
0.60
2497
23212
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
21
58
3.64
6.74
1.1
1.2
—
—
—
0
0
(3016750) Collection duration of Urine
44
187
2.37
6.62
2.0
2.0
min
462.8
494.9
0.83
27
141
(3023430) Cat dander IgE Ab [Units/volume] in Serum
36
139
2.61
6.61
1.1
1.1
u/ml
2.0
4.7
0.74
22
54
(21494755) Public health laboratory ask at order entry panel
82
1453
0.55
6.61
1.3
1.4
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
10
7
14.32
6.39
1.9
1.3
—
—
—
0
0
(3012565) Volume of 24 hour Urine
33
125
2.65
6.31
1.8
2.5
ml
1951.3
1954.7
0.01
26
112
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
12
22
5.47
6.28
1.9
1.6
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
37
149
2.50
6.26
1.0
1.1
u/ml
4.2
3.7
0.07
21
57
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
297
3951
0.73
6.23
4.6
4.8
%
32.8
33.0
0.12
204
2537
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
14
30
4.68
6.21
1.1
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
14
30
4.68
6.21
2.1
1.6
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
20
57
3.52
6.15
1.5
1.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
24
78
3.09
6.03
1.4
1.3
ug/l
9.5
9.1
0.18
24
78
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
23
73
3.16
6.01
1.4
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
23
5.23
6.00
4.4
6.5
—
—
—
0
0
(3001729) Color of Synovial fluid
14
31
4.53
5.98
2.2
1.5
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
99
587
1.71
5.89
1.2
1.1
u/ml
29.5
9.2
—
7
50
(3008401) Mugwort IgE Ab [Units/volume] in Serum
45
204
2.22
5.87
1.1
1.1
u/ml
0.5
1.2
0.56
22
83
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
99
1611
0.60
5.82
1.8
1.8
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
17
45
3.79
5.81
1.4
1.2
mmol/l
0.5
2.8
—
9
32
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
316
4121
0.75
5.80
11.2
7.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
88
507
1.75
5.80
1.3
1.2
u/l
38.3
28.2
0.49
76
437
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
19
55
3.47
5.72
1.4
1.4
%
4.3
5.7
—
10
26
(3019768) Coxiella burnetii Ab [Presence] in Serum
10
17
5.90
5.62
1.0
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
35
145
2.43
5.61
1.7
1.5
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
12
25
4.81
5.49
1.2
1.2
u/l
19.0
21.7
—
6
15
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
32
129
2.49
5.44
1.1
1.1
u/l
84.1
97.7
0.47
25
98
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
8
5
16.03
5.41
1.1
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
8
5
16.03
5.41
1.1
1.0
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
32
130
2.47
5.36
1.1
1.1
u/l
26.1
34.9
0.41
24
97
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
21
68
3.10
5.33
1.8
1.5
ug/l
0.3
0.4
0.77
16
38
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
12
26
4.63
5.25
1.0
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
46
221
2.09
5.24
7.8
3.3
%
10.4
10.8
0.24
46
221
(3044290) Cell count panel - Cerebral spinal fluid
80
464
1.74
5.19
1.2
1.4
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
29
115
2.53
5.12
1.1
1.1
iu/ml
—
2.6
—
0
5
(3038071) Oxygen [Partial pressure] in Mixed venous blood
21
70
3.01
5.09
6.6
8.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
150
1019
1.49
5.09
1.4
1.2
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
9
9
10.02
5.02
1.6
1.0
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
55
287
1.93
5.01
1.7
1.3
e6/l
155460.7
132475.2
0.09
38
198
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
57
1030
0.55
5.00
1.6
1.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
50
254
1.98
4.92
1.3
1.3
mosm/kgh2o
268.8
278.0
2.46
42
185
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
17
51
3.34
4.88
1.2
1.1
mg/l
0.9
93.0
—
10
38
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
8
7
11.45
4.78
1.6
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
11
24
4.59
4.78
1.4
1.7
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
10
20
5.01
4.77
1.3
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
29
120
2.43
4.71
1.0
1.0
u/ml
0.3
0.3
0.04
13
36
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
986
11111
0.85
4.68
4.1
4.7
%
21.4
22.2
0.80
430
5893
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
34
153
2.23
4.59
2.1
1.6
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
13
34
3.83
4.53
2.0
3.4
mmol/l
2.1
2.7
0.48
13
27
(40763480) Human metapneumovirus Ag [Presence] in Specimen
8
8
10.02
4.52
1.6
1.0
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
35
161
2.18
4.49
1.7
1.6
u/field
0.7
1.9
2.22
27
113
(3001019) Free T4 and TSH panel - Serum or Plasma
40
777
0.51
4.48
1.9
1.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3147
30437
1.21
4.37
22.4
10.0
u/l
24.7
25.6
1.92
3101
29057
(3020491) Glucose [Moles/volume] in Blood
41
205
2.01
4.26
2.0
2.1
mmol/l
7.8
6.7
1.53
35
130
(3032057) Clostridioides difficile [Presence] in Stool
17
56
3.04
4.23
2.4
1.8
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
37
180
2.07
4.15
1.6
1.3
promille
1.3
1.1
0.30
29
137
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
19
68
2.80
4.11
1.1
1.0
u/ml
17.8
3.9
—
5
9
(3014271) Vancomycin [Susceptibility]
35
168
2.09
4.07
2.9
2.7
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
8
10
8.01
4.06
2.1
6.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
48
259
1.86
4.02
2.1
1.9
u/l
128.9
4228.5
1.92
14
103
(3004775) Volume in Urine collected for unspecified duration
50
275
1.83
3.96
2.1
2.1
ml
572.2
619.6
0.37
33
178
(3020876) Protein [Mass/time] in 24 hour Urine
47
254
1.86
3.93
1.9
2.0
g/24h
0.6
1.0
—
5
9
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
15
48
3.13
3.92
1.5
1.1
—
—
—
0
0
(44813793)
29
131
2.22
3.92
1.1
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
26
113
2.31
3.84
1.4
1.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
75
468
1.61
3.80
1.9
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
697
7951
0.85
3.72
2.7
3.3
ug/l
0.7
0.8
2.23
493
5644
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
81
518
1.58
3.72
1.1
1.2
mmol/l
3.7
3.8
0.17
73
485
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
20
78
2.57
3.71
1.1
1.1
miu/ml
1715.0
1671.8
0.05
20
78
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
124
870
1.44
3.67
1.6
1.6
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
9
16
5.64
3.65
1.0
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
767
8669
0.86
3.63
3.3
3.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
52
298
1.76
3.62
1.8
1.5
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
11
31
3.56
3.48
1.3
1.0
iu/ml
3.8
9.3
—
5
12
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
31
153
2.03
3.40
1.6
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2795
26924
1.15
3.38
33.9
13.5
ml/min/173m2
73.2
74.4
2.03
2521
22118
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
6
7
8.58
3.26
1.3
5.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
30
149
2.02
3.25
2.7
3.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
65
409
1.60
3.24
4.2
1.9
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
29
143
2.04
3.20
1.4
1.2
nmol/l
1.3
1.1
0.40
23
107
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
10
28
3.58
3.19
1.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
26
123
2.12
3.19
1.0
1.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
72
466
1.56
3.19
1.5
1.4
u/l
9.2
9.2
0.01
54
368
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
88
598
1.48
3.12
1.2
1.3
mg/l
828.5
567.5
0.38
80
570
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
11
34
3.24
3.05
14.0
10.6
mmol/l
5.8
5.3
0.41
11
34
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
8
16
5.01
3.05
8.1
8.7
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
43
249
1.74
2.95
1.6
1.5
u/ml
14.7
23.9
—
9
57
(3039443) Prostate specific Ag panel - Serum or Plasma
31
565
0.54
2.95
1.5
1.6
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
11
35
3.15
2.93
1.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
13
46
2.83
2.91
2.7
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
55
342
1.62
2.91
1.7
1.4
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
10
30
3.34
2.90
1.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
18
77
2.34
2.81
1.6
2.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
704
6275
1.15
2.79
5.6
4.1
kg/l
1.0
1.0
0.16
130
970
(3034274) Bile acid [Moles/volume] in Serum --fasting
25
124
2.02
2.75
1.0
2.0
umol/l
5.9
17.2
1.21
19
77
(3008402) Methanol [Moles/volume] in Serum or Plasma
9
24
3.76
2.67
1.1
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
20
93
2.16
2.60
1.1
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
52
330
1.58
2.57
1.2
1.3
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
10
33
3.04
2.52
1.5
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
10
33
3.04
2.52
1.3
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2813
28939
0.89
2.51
5.2
5.3
mmol/l
2.5
2.6
14.69
2506
26153
(3003694) ABO and Rh group [Type] in Blood
815
7390
1.13
2.49
1.5
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
20
95
2.11
2.48
2.4
1.5
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
7
16
4.38
2.47
1.1
1.3
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
8
21
3.82
2.46
1.3
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2797
27142
1.12
2.38
6.9
6.3
mmol/mol
41.8
40.4
8.01
2589
24701
(3022229) Phosphate [Moles/volume] in Urine
5
8
6.26
2.37
1.2
3.1
mmol/l
15.5
18.1
—
5
8
(3030313) Adrenal Ab [Titer] in Serum
5
8
6.26
2.37
1.4
1.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
62
418
1.49
2.36
3.1
2.0
mg/l
24.1
31.3
0.51
20
92
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
22
111
1.99
2.35
1.1
1.2
%
53.6
64.0
—
5
9
(3023511) Choriogonadotropin [Units/volume] in Urine
22
111
1.99
2.35
1.3
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
18
84
2.15
2.34
1.2
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
33
191
1.73
2.33
1.6
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2740
28192
0.90
2.32
4.8
4.7
mmol/l
4.4
4.5
8.43
2434
25593
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
10
35
2.86
2.30
1.0
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
68
474
1.44
2.21
1.5
1.4
iu/l
31.1
30.0
0.08
52
396
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
9
5.56
2.21
1.2
1.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
13
54
2.41
2.19
1.1
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
68
957
0.71
2.18
1.1
1.2
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
8
24
3.34
2.18
1.4
1.3
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
6
14
4.29
2.15
1.0
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
13
55
2.37
2.12
1.1
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
19
95
2.01
2.10
3.1
2.4
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
5
10
5.00
2.07
1.6
9.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
39
245
1.60
2.06
1.3
1.4
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
7
20
3.50
2.05
1.1
1.2
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
7
20
3.50
2.05
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2717
27912
0.90
2.05
4.7
4.6
mmol/l
1.4
1.4
3.66
2403
25162
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
6
15
4.00
2.04
1.2
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
141
1123
1.27
1.96
1.6
1.8
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
21
112
1.88
1.96
1.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
27
2.97
1.93
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
14
282
0.49
1.93
2.2
1.6
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
11
45
2.45
1.93
1.1
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
22
120
1.84
1.92
1.0
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
55
380
1.45
1.91
2.0
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
184
1516
1.22
1.90
2.9
2.9
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
66
473
1.40
1.89
1.3
1.7
mu/l
323.1
299.7
0.22
60
439
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
43
284
1.52
1.87
1.8
1.9
u/field
1.1
1.9
0.99
22
97
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
9
34
2.65
1.86
1.0
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
20
107
1.87
1.86
1.2
1.2
g/l
32.1
39.3
—
9
51
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
153
1243
1.24
1.81
1.5
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
164
1343
1.23
1.81
1.2
1.2
iu/ml
106.8
135.6
0.43
49
501
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
13
60
2.17
1.77
1.5
1.1
pmol/l
339.7
313.0
—
7
45
(3032773) Endomysium IgG Ab [Titer] in Serum
31
192
1.62
1.77
1.0
1.1
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
17
88
1.94
1.74
3.2
3.0
mu/l
11.6
19.0
2.06
17
79
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
201
1689
1.20
1.73
2.3
2.4
au/ml
61.2
29.3
—
5
61
(3002256) Pathology report gross observation
444
3969
1.13
1.72
1.4
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
3194
31377
1.12
1.72
53.0
20.6
e9/l
248.5
238.9
11.39
3138
30383
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
20
111
1.81
1.68
1.5
1.3
—
—
—
0
0
(3035941) MCH [Entitic mass]
3194
31385
1.12
1.68
52.7
20.5
pg
30.4
30.5
2.47
3157
30811
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
70
519
1.36
1.67
1.2
1.5
e6/l
103.6
776.7
2.35
54
433
(3024731) MCV [Entitic volume]
3194
31387
1.12
1.67
52.8
20.5
fl
92.3
91.6
12.40
3155
30810
(3026361) Erythrocytes [#/volume] in Blood
3194
31388
1.12
1.67
52.9
20.5
e12/l
4.3
4.5
41.45
3127
30267
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
87
667
1.31
1.66
2.8
3.2
u/ml
76.8
823.8
1.20
79
604
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
28
440
0.63
1.64
1.4
1.5
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
3194
31395
1.12
1.63
53.0
20.6
e9/l
8.1
6.7
82.67
3129
30274
(3000963) Hemoglobin [Mass/volume] in Blood
3194
31396
1.12
1.63
53.4
20.7
g/l
129.4
134.9
75.41
3157
30832
(4198724)
12
56
2.15
1.61
1.2
5.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
40
271
1.48
1.58
2.4
2.4
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
20
3.00
1.58
1.0
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
11
50
2.20
1.57
5.4
8.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
265
2305
1.16
1.54
2.8
2.1
nmol/l
12.0
12.2
0.13
229
2003
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
69
519
1.34
1.53
1.1
1.4
e6/l
23.1
14.5
0.26
49
412
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
145
1197
1.22
1.52
3.1
3.3
u/ml
242.6
4537.7
1.15
120
1031
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
45
315
1.43
1.52
1.5
1.3
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
6
21
2.86
1.50
1.0
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
6
21
2.86
1.50
1.2
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
24
146
1.65
1.50
2.3
2.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
178
1506
1.19
1.46
1.3
1.3
au/ml
21.6
62.5
—
5
61
(3043410) Blood group antigens tested for on Red Blood Cells
15
80
1.88
1.44
1.7
1.5
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
7
29
2.42
1.39
1.1
1.0
—
—
—
0
0
(4027681)
19
111
1.72
1.39
1.1
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
45
322
1.40
1.37
2.2
2.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
20
119
1.68
1.37
1.5
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
165
0.48
1.34
1.9
1.9
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
15
83
1.81
1.31
19.3
12.0
nmol/l
904.3
816.3
0.29
15
77
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1314
13750
0.93
1.29
4.6
5.5
ug/l
4.4
4.5
0.02
1132
12234
(3019174) dRVVT (LA screen)
5
18
2.78
1.28
1.2
1.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
47
346
1.36
1.24
1.5
1.3
nmol/l
20.2
0.6
0.49
41
336
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
12
63
1.91
1.22
1.1
1.0
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
47
347
1.36
1.22
1.5
1.3
nmol/l
0.2
0.3
—
8
23
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
5
19
2.63
1.21
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
124
1.62
1.20
1.1
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
22
140
1.57
1.20
3.5
6.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
228
2006
1.15
1.19
4.6
3.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
26
2.31
1.18
1.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
48
358
1.35
1.18
2.2
1.7
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
12
64
1.88
1.18
1.1
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
9
171
0.53
1.17
1.4
1.4
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
11
57
1.93
1.17
2.0
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
294
2635
1.13
1.16
4.9
3.4
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
5
20
2.50
1.15
1.6
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
48
360
1.34
1.14
2.2
2.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
12
65
1.85
1.13
1.0
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
30
2.34
1.12
1.0
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
47
353
1.34
1.12
2.1
2.2
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
13
73
1.78
1.10
1.1
1.3
g/l
0.4
0.3
—
8
54
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
303
2732
1.12
1.09
1.7
1.6
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
5
21
2.38
1.09
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
154
1782
0.86
1.09
1.1
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
41
303
1.36
1.08
3.2
4.0
umol/l
299.4
350.9
1.32
32
249
(3000764) Benzodiazepines [Presence] in Urine
47
356
1.32
1.07
2.2
2.3
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
7
33
2.12
1.05
1.0
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
67
534
1.26
1.05
1.6
1.7
iu/l
4.3
4.2
0.02
18
173
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
118
998
1.19
1.04
1.7
1.7
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
148
0.54
1.03
1.4
1.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
148
0.54
1.03
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
148
0.54
1.03
1.4
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
148
0.54
1.03
1.4
1.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
34
2.06
1.02
1.0
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
7
35
2.00
1.00
1.7
2.2
u/field
0.4
0.3
—
7
35
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
29
0.00
0.97
0.0
1.1
—
28.1
—
0
20
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
25
173
1.45
0.97
1.7
1.6
nmol/l
0.2
0.2
1.10
20
132
(4281824)
19
283
0.67
0.96
1.1
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2649
26958
0.94
0.96
4.3
4.1
mmol/l
1.3
1.3
7.51
2337
24067
(3000330) Specific gravity of Urine by Test strip
149
1707
0.87
0.95
5.2
3.4
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
32
0.00
0.95
0.0
1.7
—
8.0
—
0
18
(3019225) pH of Specimen
355
3259
1.10
0.94
5.8
4.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
12
70
1.72
0.92
1.0
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
11
63
1.75
0.90
1.2
1.1
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
29
2.07
0.89
1.3
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
71
1.69
0.88
1.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
153
0.59
0.88
1.3
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
7
127
0.55
0.88
1.1
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
75
621
1.21
0.87
1.8
1.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
37
281
1.32
0.86
2.2
3.2
mg/l
50.1
29.2
0.36
30
220
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
15
96
1.56
0.84
1.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
8
46
1.74
0.82
2.3
1.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
30
223
1.35
0.81
1.3
1.6
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
7
122
0.57
0.77
1.1
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
7
122
0.57
0.77
1.1
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
23
165
1.40
0.77
2.0
1.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
18
123
1.47
0.77
1.0
1.1
nmol/l
140.6
134.4
0.15
18
123
(3011335) Digoxin [Mass/volume] in Serum or Plasma
6
34
1.77
0.76
2.5
2.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
29
218
1.33
0.75
11.9
3.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
24
2.08
0.74
1.0
2.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2352
23100
1.05
0.73
47.8
18.4
g/l
328.7
332.3
61.03
2331
22885
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
108
0.55
0.72
1.3
1.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
20
143
1.40
0.70
1.1
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
14
93
1.51
0.69
1.0
1.3
—
—
—
0
0
(4094501)
67
791
0.84
0.68
1.1
1.1
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
5
27
1.85
0.68
1.0
2.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
95
826
1.15
0.67
2.6
2.2
ug/min
114.8
76.7
0.52
61
484
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
5
28
1.79
0.66
1.0
1.1
u/ml
31.4
57.6
—
5
28
(3008898) HLA-B27 [Presence]
72
616
1.17
0.64
1.1
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
30
1.67
0.61
1.0
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
8
50
1.60
0.61
1.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
16
221
0.72
0.60
1.0
1.0
ng/l
30.8
47.5
—
8
145
(3015183) Erythrocyte sedimentation rate
12
80
1.50
0.59
1.2
1.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
12
174
0.69
0.59
1.4
1.3
pmol/l
60.8
265.5
—
6
46
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
16
220
0.73
0.58
1.0
1.0
ng/l
806.5
693.4
—
6
139
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
16
220
0.73
0.58
1.0
1.0
ng/l
289.9
347.9
—
8
144
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
8
53
1.51
0.58
1.8
2.8
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
33
264
1.25
0.58
1.0
1.1
u/ml
31.8
2.8
—
8
95
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
8
54
1.48
0.57
3.0
1.8
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
6
36
1.67
0.56
1.7
7.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
16
115
1.39
0.56
1.0
1.1
u/l
1.0
1.2
—
9
64
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
55
1.46
0.56
1.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
37
1.62
0.55
2.0
2.3
—
—
—
0
0
(4034850)
109
975
1.12
0.54
14.9
10.7
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
23
177
1.30
0.54
7.3
16.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
38
1.58
0.54
2.0
2.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
63
543
1.16
0.54
1.5
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
48
405
1.19
0.52
1.1
1.1
iu/ml
89.5
65.4
0.12
13
75
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
64
737
0.87
0.52
2.1
1.7
mg/l
35.7
3.9
5.62
58
532
(3005570) Glucose [Moles/volume] in Urine
36
296
1.22
0.51
2.6
1.8
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
11
75
1.47
0.50
1.9
1.3
pmol/l
18.5
15.5
—
6
58
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
37
306
1.21
0.50
1.6
1.3
nmol/l
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
144
1317
1.10
0.49
2.6
2.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
7
45
1.56
0.49
1.9
3.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
258
2749
0.93
0.48
1.4
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
808
7820
1.04
0.48
1.8
1.6
mmol/l
1.5
1.3
5.48
670
6492
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
25
199
1.26
0.47
1.1
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
7
47
1.49
0.47
1.6
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
28
343
0.81
0.46
1.3
1.4
mu/l
44.5
66.5
0.63
23
303
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
32
1.56
0.42
1.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
27
327
0.82
0.41
1.1
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
70
1.43
0.41
1.2
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
25
205
1.22
0.39
3.7
4.8
u/ml
105.6
38.4
—
8
60
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
16
124
1.29
0.38
1.2
1.5
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
36
1.39
0.38
1.0
1.2
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
10
136
0.73
0.37
1.4
1.3
mmol/l
6.3
6.1
—
10
128
(3020874) Milk IgE Ab [Units/volume] in Serum
11
81
1.36
0.36
1.0
1.1
u/ml
1.0
1.3
—
6
28
(4146454)
33
385
0.86
0.35
2.8
2.8
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
6
42
1.43
0.35
1.0
2.5
—
107.1
—
0
21
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
14
109
1.29
0.33
1.0
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
64
706
0.90
0.31
3.4
2.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
7
54
1.30
0.30
1.1
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
16
196
0.82
0.30
1.2
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
11
141
0.78
0.29
1.2
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
28
323
0.87
0.28
1.3
1.4
pmol/l
210.0
266.5
0.67
22
238
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
60
546
1.10
0.28
2.4
1.6
nmol/l
1.1
0.8
1.64
48
451
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
42
470
0.89
0.27
2.1
1.9
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
8
64
1.25
0.27
1.4
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
87
934
0.93
0.25
5.7
4.0
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
26
298
0.87
0.25
1.2
1.2
mmol/l
7.5
7.6
0.05
18
202
(3020650) Glucose [Presence] in Urine
10
78
1.28
0.24
1.7
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2807
28226
0.98
0.23
5.3
5.0
mmol/l
6.1
6.1
0.09
2525
25188
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(44806420)
14
116
1.21
0.22
1.6
2.7
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
51
468
1.09
0.21
1.9
2.0
pmol/l
202.1
200.4
0.04
44
437
(3041806) Other cells [#/volume] in Blood by Manual count
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
10
0.00
0.21
0.0
1.1
—
7.8
—
0
10
(3006270) Folate [Moles/volume] in Blood
25
282
0.89
0.20
1.1
1.2
nmol/l
281.6
334.5
0.67
19
229
(3051387) C reactive protein [Mass/volume] in Capillary blood
71
665
1.07
0.19
7.6
3.2
mg/l
31.1
28.7
0.25
56
413
(3044007) Cell count panel - Peritoneal fluid
11
90
1.22
0.19
2.1
1.8
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
10
120
0.83
0.16
1.0
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
68
1.18
0.16
1.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
7
87
0.80
0.14
1.1
1.4
—
—
—
0
0
(4211845)
19
170
1.12
0.13
3.9
3.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
117
1128
1.04
0.13
1.1
1.0
—
—
—
0
0
(4024509)
35
326
1.07
0.12
1.7
1.6
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
19
175
1.09
0.08
1.1
1.2
mmol/l
10.7
11.6
—
8
50
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
5
62
0.81
0.08
2.2
2.0
nmol/l
136.6
154.3
—
5
54
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
36
379
0.95
0.08
1.7
1.8
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
17
156
1.09
0.08
4.2
3.8
—
—
—
0
0
(4133840)
7
66
1.06
0.08
1.0
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
43
445
0.97
0.05
1.7
1.5
pmol/l
208.0
266.1
0.31
43
434
(3023487) Leukocytes [#/volume] in Peritoneal fluid
10
110
0.91
0.05
2.2
2.0
e6/l
163.4
704.6
—
5
80
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
54
555
0.97
0.04
1.4
1.3
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
13
132
0.98
0.00
1.0
1.1
—
—
—
0
0
(1002224) Polysomnography panel
81
806
1.01
0.00
1.1
1.1
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
6
63
0.95
0.00
1.0
1.0
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
1978.0
—
0
5
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
52
0.96
0.00
1.4
1.2
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
6
0.00
0.00
0.0
6.7
—
59.2
—
0
6
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
8
89
0.90
0.00
1.9
2.4
ug/l
1.2
1.3
—
8
83
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.3
—
0
5
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028714) Urate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
224.8
—
0
8
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
9
93
0.97
0.00
2.3
1.9
—
—
—
0
0
(4038314)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ILD_HOSPITAL_PULM_INFECT – ILD, hospital admission 2, with pulmonary infections
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).